<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.0 20040830//EN" "http://dtd.nlm.nih.gov/publishing/2.0/journalpublishing.dtd">
<?covid-19-tdm?>
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="2.0">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">JFR</journal-id>
      <journal-id journal-id-type="nlm-ta">JMIR Form Res</journal-id>
      <journal-title>JMIR Formative Research</journal-title>
      <issn pub-type="epub">2561-326X</issn>
      <publisher>
        <publisher-name>JMIR Publications</publisher-name>
        <publisher-loc>Toronto, Canada</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">v6i7e38781</article-id>
      <article-id pub-id-type="pmid">35781223</article-id>
      <article-id pub-id-type="doi">10.2196/38781</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Paper</subject>
        </subj-group>
        <subj-group subj-group-type="article-type">
          <subject>Original Paper</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Development of a Theory-Based, Culturally Appropriate Message Library for Use in Interventions to Promote COVID-19 Vaccination Among African Americans: Formative Research</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Mavragani</surname>
            <given-names>Amaryllis</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="reviewer">
          <name>
            <surname>Gwadz</surname>
            <given-names>Maria</given-names>
          </name>
        </contrib>
        <contrib contrib-type="reviewer">
          <name>
            <surname>Martin</surname>
            <given-names>Nan</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib id="contrib1" contrib-type="author" corresp="yes">
          <name name-style="western">
            <surname>Cunningham-Erves</surname>
            <given-names>Jennifer</given-names>
          </name>
          <degrees>MAEd, MS, MPH, PhD</degrees>
          <xref rid="aff1" ref-type="aff">1</xref>
          <address>
            <institution>Department of Internal Medicine</institution>
            <institution>Meharry Medical College</institution>
            <addr-line>1005 Dr DB Todd Jr Blvd</addr-line>
            <addr-line>Nashville, TN, 37208</addr-line>
            <country>United States</country>
            <phone>1 251 714 4233</phone>
            <email>jerves@mmc.edu</email>
          </address>
          <ext-link ext-link-type="orcid">https://orcid.org/0000-0002-7780-9874</ext-link>
        </contrib>
        <contrib id="contrib2" contrib-type="author">
          <name name-style="western">
            <surname>Brandt</surname>
            <given-names>Heather M</given-names>
          </name>
          <degrees>PhD</degrees>
          <xref rid="aff2" ref-type="aff">2</xref>
          <ext-link ext-link-type="orcid">https://orcid.org/0000-0003-1066-2879</ext-link>
        </contrib>
        <contrib id="contrib3" contrib-type="author">
          <name name-style="western">
            <surname>Sanderson</surname>
            <given-names>Maureen</given-names>
          </name>
          <degrees>PhD</degrees>
          <xref rid="aff3" ref-type="aff">3</xref>
          <ext-link ext-link-type="orcid">https://orcid.org/0000-0002-3914-6870</ext-link>
        </contrib>
        <contrib id="contrib4" contrib-type="author">
          <name name-style="western">
            <surname>Clarkson</surname>
            <given-names>Kristin</given-names>
          </name>
          <degrees>MHA</degrees>
          <xref rid="aff4" ref-type="aff">4</xref>
          <ext-link ext-link-type="orcid">https://orcid.org/0000-0002-0523-4469</ext-link>
        </contrib>
        <contrib id="contrib5" contrib-type="author">
          <name name-style="western">
            <surname>Lee</surname>
            <given-names>Omaran</given-names>
          </name>
          <degrees>MDiv</degrees>
          <xref rid="aff4" ref-type="aff">4</xref>
          <ext-link ext-link-type="orcid">https://orcid.org/0000-0001-6055-7116</ext-link>
        </contrib>
        <contrib id="contrib6" contrib-type="author">
          <name name-style="western">
            <surname>Schlundt</surname>
            <given-names>David</given-names>
          </name>
          <degrees>PhD</degrees>
          <xref rid="aff5" ref-type="aff">5</xref>
          <ext-link ext-link-type="orcid">https://orcid.org/0000-0001-7069-9644</ext-link>
        </contrib>
        <contrib id="contrib7" contrib-type="author">
          <name name-style="western">
            <surname>Bonnet</surname>
            <given-names>Kemberlee</given-names>
          </name>
          <degrees>MA</degrees>
          <xref rid="aff5" ref-type="aff">5</xref>
          <ext-link ext-link-type="orcid">https://orcid.org/0000-0003-4046-3408</ext-link>
        </contrib>
        <contrib id="contrib8" contrib-type="author">
          <name name-style="western">
            <surname>Davis</surname>
            <given-names>Jamaine</given-names>
          </name>
          <degrees>PhD</degrees>
          <xref rid="aff6" ref-type="aff">6</xref>
          <ext-link ext-link-type="orcid">https://orcid.org/0000-0002-5078-1306</ext-link>
        </contrib>
      </contrib-group>
      <aff id="aff1">
        <label>1</label>
        <institution>Department of Internal Medicine</institution>
        <institution>Meharry Medical College</institution>
        <addr-line>Nashville, TN</addr-line>
        <country>United States</country>
      </aff>
      <aff id="aff2">
        <label>2</label>
        <institution>Department of Epidemiology and Cancer Control</institution>
        <institution>St Jude Children's Research Hospital</institution>
        <addr-line>Memphis, TN</addr-line>
        <country>United States</country>
      </aff>
      <aff id="aff3">
        <label>3</label>
        <institution>Department of Family Medicine</institution>
        <institution>Meharry Medical College</institution>
        <addr-line>Nashville, TN</addr-line>
        <country>United States</country>
      </aff>
      <aff id="aff4">
        <label>4</label>
        <institution>Nashville General Hospital</institution>
        <addr-line>Nashville, TN</addr-line>
        <country>United States</country>
      </aff>
      <aff id="aff5">
        <label>5</label>
        <institution>Department of Psychology</institution>
        <institution>Vanderbilt University</institution>
        <addr-line>Nashville, TN</addr-line>
        <country>United States</country>
      </aff>
      <aff id="aff6">
        <label>6</label>
        <institution>Department of Biochemistry and Cancer Biology</institution>
        <institution>Meharry Medical College</institution>
        <addr-line>Nashville, TN</addr-line>
        <country>United States</country>
      </aff>
      <author-notes>
        <corresp>Corresponding Author: Jennifer Cunningham-Erves <email>jerves@mmc.edu</email></corresp>
      </author-notes>
      <pub-date pub-type="collection">
        <month>7</month>
        <year>2022</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>28</day>
        <month>7</month>
        <year>2022</year>
      </pub-date>
      <volume>6</volume>
      <issue>7</issue>
      <elocation-id>e38781</elocation-id>
      <history>
        <date date-type="received">
          <day>15</day>
          <month>4</month>
          <year>2022</year>
        </date>
        <date date-type="rev-request">
          <day>26</day>
          <month>5</month>
          <year>2022</year>
        </date>
        <date date-type="rev-recd">
          <day>23</day>
          <month>6</month>
          <year>2022</year>
        </date>
        <date date-type="accepted">
          <day>27</day>
          <month>6</month>
          <year>2022</year>
        </date>
      </history>
      <copyright-statement>©Jennifer Cunningham-Erves, Heather M Brandt, Maureen Sanderson, Kristin Clarkson, Omaran Lee, David Schlundt, Kemberlee Bonnet, Jamaine Davis. Originally published in JMIR Formative Research (https://formative.jmir.org), 28.07.2022.</copyright-statement>
      <copyright-year>2022</copyright-year>
      <license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/">
        <p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Formative Research, is properly cited. The complete bibliographic information, a link to the original publication on https://formative.jmir.org, as well as this copyright and license information must be included.</p>
      </license>
      <self-uri xlink:href="https://formative.jmir.org/2022/7/e38781" xlink:type="simple"/>
      <abstract>
        <sec sec-type="background">
          <title>Background</title>
          <p>Disparities in COVID-19 incidence, hospitalization, and mortality rates among African Americans suggest the need for targeted interventions. Use of targeted, theory-driven messages in behavioral and communication interventions could empower African Americans to engage in behaviors that prevent COVID-19.</p>
        </sec>
        <sec sec-type="objective">
          <title>Objective</title>
          <p>To address this need, we performed a formative study that aimed to develop and design a culturally appropriate, theory-based library of messages targeting concerns around COVID-19 vaccines that could be used in behavioral and communication interventions for African Americans.</p>
        </sec>
        <sec sec-type="methods">
          <title>Methods</title>
          <p>Message development occurred between January 2021 and February 2022. Initial messages were designed by a multidisciplinary team of researchers, community leaders, and community members. Kreuter’s 5 strategies (ie, linguistic, peripheral, evidential, sociocultural, and constituent-involving strategies) were used to achieve cultural appropriateness. After forming a community-academic partnership, message development occurred in 4 phases: (1) adaptation of a message library using the literature, (2) review by 6 clinical and research experts for content validation, (3) input and review by a 6-member community advisory panel (CAP), and (4) message pretesting with African Americans via semistructured interviews in a qualitative study.</p>
        </sec>
        <sec sec-type="results">
          <title>Results</title>
          <p>Themes from the semistructured interviews among 30 African Americans were as follows: (1) community reactions to the messages, (2) community questions and information needs, (3) suggestions for additional content, and (4) suggestions to improve comprehension, relevance, and trustworthiness. Feedback from the CAP, community members, and scientific experts was used by members of the community-academic partnership to iteratively update message content to maximize cultural appropriateness. The final message library had 18 message subsets for adults and 17 message subsets for parents and caregivers of children. These subsets were placed into 3 categories: (1) vaccine development, (2) vaccine safety, and (3) vaccine effectiveness.</p>
        </sec>
        <sec sec-type="conclusions">
          <title>Conclusions</title>
          <p>We used a 4-phase, systematic process using multiple community engagement approaches to create messages for African Americans to support interventions to improve COVID-19 vaccination rates among adults and children. The newly developed messages were deemed to be culturally appropriate according to experts and members of the African American community. Future research should evaluate the impact of these messages on COVID-19 vaccination rates among African Americans.</p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd>African American</kwd>
        <kwd>Black American</kwd>
        <kwd>Black</kwd>
        <kwd>minority</kwd>
        <kwd>ethnic</kwd>
        <kwd>culturally sensitive</kwd>
        <kwd>cultural sensitivity</kwd>
        <kwd>inclusive</kwd>
        <kwd>vulnerable</kwd>
        <kwd>COVID-19</kwd>
        <kwd>vaccination</kwd>
        <kwd>vaccine</kwd>
        <kwd>health promotion</kwd>
        <kwd>campaign</kwd>
        <kwd>messaging</kwd>
        <kwd>culturally appropriate</kwd>
        <kwd>theory</kwd>
        <kwd>adults</kwd>
        <kwd>children</kwd>
        <kwd>disparity</kwd>
        <kwd>health belief model</kwd>
        <kwd>community engagement</kwd>
        <kwd>public engagement</kwd>
        <kwd>public awareness</kwd>
        <kwd>community-based</kwd>
        <kwd>health information</kwd>
        <kwd>health communication</kwd>
        <kwd>health intervention</kwd>
        <kwd>vulnerable population</kwd>
        <kwd>community health</kwd>
        <kwd>patient education</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="introduction">
      <title>Introduction</title>
      <sec>
        <title>Background</title>
        <p>Since December 2020, 3 vaccines have been approved in the United States to prevent severe disease and death caused by COVID-19. The 2-dose vaccinations developed by <italic>Pfizer</italic> and <italic>Moderna</italic> are approved for use in individuals aged 18 years and older and under emergency use authorization (EAU) for children aged 6 months to 17 years [<xref ref-type="bibr" rid="ref1">1</xref>]. The 1-dose <italic>Johnson &#38; Johnson</italic> vaccination is under EAU for adults aged 18 years and older [<xref ref-type="bibr" rid="ref1">1</xref>]. Although highly effective [<xref ref-type="bibr" rid="ref2">2</xref>], vaccination rates remain suboptimal, especially among populations who could benefit most. For example, African Americans comprise 12.4% of the US population but only 10.1% of those who have initiated the series and 10.3% of those who have completed the series as of March 10, 2022 [<xref ref-type="bibr" rid="ref3">3</xref>]. Despite African Americans being almost 2 times more likely than White Americans to die from COVID-19 [<xref ref-type="bibr" rid="ref4">4</xref>], vaccine hesitancy remains a major hindrance to reduced vaccine uptake among African Americans [<xref ref-type="bibr" rid="ref5">5</xref>-<xref ref-type="bibr" rid="ref9">9</xref>].</p>
        <p>Emerging studies demonstrate that vaccine hesitancy is deeply rooted in several overlapping areas: (1) mistrust in health care, government, and research [<xref ref-type="bibr" rid="ref10">10</xref>-<xref ref-type="bibr" rid="ref13">13</xref>]; (2) structural racism [<xref ref-type="bibr" rid="ref14">14</xref>]; and (3) lack of understanding of science related to vaccine-specific issues (eg, efficacy, safety, speed of development) [<xref ref-type="bibr" rid="ref13">13</xref>,<xref ref-type="bibr" rid="ref15">15</xref>]. Lack of information, misinformation, and disinformation further drive vaccine hesitancy [<xref ref-type="bibr" rid="ref10">10</xref>], with social or mass media as the primary source [<xref ref-type="bibr" rid="ref15">15</xref>]. Because effective communication is necessary to help African Americans make informed decisions about COVID-19 vaccines [<xref ref-type="bibr" rid="ref16">16</xref>], studies have begun to explore the communication strategies necessary to increase COVID-19 vaccination [<xref ref-type="bibr" rid="ref17">17</xref>-<xref ref-type="bibr" rid="ref19">19</xref>]. Trusted messengers are key to COVID-19 information being well received and used [<xref ref-type="bibr" rid="ref20">20</xref>].</p>
        <p>The specific messages related to COVID-19 vaccination are as important as the messenger. Information sources have been developed and disseminated widely to educate communities on messages to use to educate communities on COVID-19 vaccination to increase uptake [<xref ref-type="bibr" rid="ref21">21</xref>,<xref ref-type="bibr" rid="ref22">22</xref>]. A few emerging studies have tested messages, including persuasive messaging [<xref ref-type="bibr" rid="ref18">18</xref>], video-based messages [<xref ref-type="bibr" rid="ref23">23</xref>], and behavioral nudges [<xref ref-type="bibr" rid="ref24">24</xref>], on vaccination intention or uptake. African Americans suggest the need for messages that are accurate, targeted, culturally appropriate, and community based [<xref ref-type="bibr" rid="ref25">25</xref>,<xref ref-type="bibr" rid="ref26">26</xref>]. However, perceptions of the messages remain unknown, and none (to the best of our knowledge) have actively engaged the African American community to develop or refine the messages on COVID-19 vaccination to ensure cultural appropriateness. Such engagement is key because African Americans’ values and decision-making about the COVID-19 vaccine are strongly shaped by culture [<xref ref-type="bibr" rid="ref10">10</xref>,<xref ref-type="bibr" rid="ref12">12</xref>,<xref ref-type="bibr" rid="ref13">13</xref>,<xref ref-type="bibr" rid="ref27">27</xref>], and targeting will maximize “fit” of information to an individual’s unique characteristics [<xref ref-type="bibr" rid="ref28">28</xref>,<xref ref-type="bibr" rid="ref29">29</xref>].</p>
      </sec>
      <sec>
        <title>Conceptual Framework</title>
        <p>Message development was guided by 2 psychosocial decision-making models: (1) theory of reasoned action (TRA) [<xref ref-type="bibr" rid="ref30">30</xref>] and (2) the Health Belief Model (HBM) [<xref ref-type="bibr" rid="ref31">31</xref>]. These health behavior theoretical models are commonly used to understand vaccination decision-making. The TRA predicts that behavioral intentions to vaccinate against COVID-19 are based on attitudes and subjective norms. The HBM predicts that the likelihood of vaccinating against COVID-19 is based on perceived susceptibility of the individual to SARS-CoV-2, perceived severity of COVID-19, and whether perceived benefits of vaccination outweigh perceived barriers.</p>
        <p>Kreuter et al [<xref ref-type="bibr" rid="ref32">32</xref>] proposed 5 strategies to achieve cultural appropriateness that were used to guide message development. <italic>Peripheral strategies</italic> increase communication appeal through the title, fonts, colors, and images. <italic>Evidential strategies</italic> provide data on impact of a health issue in a certain group. <italic>Sociocultural strategies</italic> address health issues from the social and cultural values of a group. <italic>Linguistic strategies</italic> fit the program to the native language of a certain group. Lastly, <italic>constituent-involving strategies</italic> ensure community members’ inclusion in program planning. Developing culturally appropriate, theory-based messages that can be used in communication and behavioral interventions may address concerns about COVID-19 vaccination among African Americans. Because social marketing campaigns have been effective in changing knowledge, attitudes, intentions, and behavior at the community level [<xref ref-type="bibr" rid="ref33">33</xref>-<xref ref-type="bibr" rid="ref35">35</xref>], they can disseminate theory-based, culturally appropriate messages and potentially increase COVID-19 vaccination acceptability and uptake. Social marketing is “the application of proven concepts and techniques drawn from the commercial sector to promote changes in diverse socially important behaviors such as drug use, sexual behavior…This marketing approach has an immense potential to affect major social problems if we can only learn how to harness its power” [<xref ref-type="bibr" rid="ref34">34</xref>].</p>
      </sec>
      <sec>
        <title>Study Objectives</title>
        <p>We describe the development of a theory-based, culturally appropriate library of motivational messages for a social marketing campaign to promote COVID-19 vaccination among African Americans who are vaccine hesitant. Message development occurred in 4 phases: (1) adaptation of a message library based on the literature, (2) review by clinical and research experts for content validation, (3) input and review by a community advisory panel (CAP), and (4) message pretesting via a qualitative study with African American community members to evaluate the accuracy, relevance, and persuasiveness of the messages. The long-term goal is for these messages to be used within interventions aimed at increasing COVID-19 vaccination among African Americans.</p>
      </sec>
    </sec>
    <sec sec-type="methods">
      <title>Methods</title>
      <sec>
        <title>Study Design</title>
        <p>We conducted a formative study to design and develop a theory-based, culturally appropriate message library that could be used in behavioral and communication interventions to increase COVID-19 vaccine uptake among African Americans. In the existing COVID-19 library, 1 message subset for adults and 1 for parents and caregivers of adolescents was developed and iteratively adapted by coauthors JCE (a behavioral scientist with a background in biology and vaccine hesitancy) and JD (a basic scientist with a background in infectious disease) on the basis of emerging literature and feedback from over 30 educational sessions provided to communities on COVID-19 and the vaccine. A community-academic partnership was formed to iteratively adapt the message library over a 1-year period to ensure that it was theory based, culturally appropriate, and up to date. Our adaptation process occurred through 6 phases, with community input at each phase. See <xref rid="figure1" ref-type="fig">Figure 1</xref> for a depiction of the 1-year process to yield the final message library of adult and parent message sets.</p>
        <fig id="figure1" position="float">
          <label>Figure 1</label>
          <caption>
            <p>Message library development process.</p>
          </caption>
          <graphic xlink:href="formative_v6i7e38781_fig1.png" alt-version="no" mimetype="image" position="float" xlink:type="simple"/>
        </fig>
      </sec>
      <sec>
        <title>Development of a Community-Academic Partnership, January 2021</title>
        <p>A community-academic partnership was developed between 2 academic partners, Meharry Medical College and St Jude Children’s Research Hospital, and 1 community partner, the Congregational Health and Education Network (CHEN) in 2021. This partnership yielded an interdisciplinary team of experts in basic science, epidemiology, behavioral science, communication, and community engagement. The purpose of this partnership was (1) to develop messages and products for a social marketing campaign using community engagement principles and (2) to implement and evaluate the social marketing campaign. CHEN, a 501c(3), is a collaboration between Nashville General Hospital at Meharry Medical College and other academic institutions, along with faith-based organizations serving African American and Latino congregants [<xref ref-type="bibr" rid="ref36">36</xref>]. A focus for CHEN during the COVID-19 pandemic was to improve vaccine health literacy and uptake to reduce health inequities in vaccination and related outcomes. The community partner (CHEN) ensured that the messaging represented the top vaccination concerns and was culturally appropriate. The academic partners offered guidance, when needed, to ensure that the partnership was equitable, and bidirectional engagement occurred in all research phases. They also ensured scientific accuracy of messages.</p>
      </sec>
      <sec>
        <title>Adaptation of the Existing Message Library, May-January 2022</title>
        <p>Members of the research team conducted a literature search to identify reasons for COVID-19 vaccine hesitancy and acceptance, along with potential strategies to improve coverage among African Americans. See <xref ref-type="supplementary-material" rid="app1">Multimedia Appendix 1</xref> for the methods and results of the search. This search was conducted from May 2021 until January 2022 to ensure that the library had the latest updates before the launch of the social marketing campaign. Using the literature, the TRA [<xref ref-type="bibr" rid="ref30">30</xref>] and the HBM [<xref ref-type="bibr" rid="ref31">31</xref>], and the experiences and skills of the research team, we adapted the existing message library to ensure accuracy and relevance.</p>
      </sec>
      <sec>
        <title>Input from the Community Advisory Panel, June 2021-February 2022</title>
        <p>An 8-member CAP was formed to provide feedback on concerns about the vaccine and potential strategies to increase vaccination. This panel meets quarterly and comprises African Americans in the Nashville, Tennessee, metropolitan statistical area. Organizations represented included the Matthew Walker Comprehensive Health Center, Health Leads, the National Association for the Advancement of Colored People, the Community Partners’ Network, and the Nashville Health Disparities Coalition. Additional members included a young adult, a physician, and a parent. A subgroup of the CAP (n=4, 50%) reviewed the content and provided feedback on the messages. The feedback from the meetings and content review from the subgroup were used to iteratively develop the messages and images for the library.</p>
      </sec>
      <sec>
        <title>Message Pretesting With African Americans, October 2021-January 2022</title>
        <sec>
          <title>Study Design</title>
          <p>We conducted a phenomenological, qualitative study [<xref ref-type="bibr" rid="ref37">37</xref>] to create messages that could be used to assist in decision-making on COVID-19 vaccination among African Americans. Specifically, we conducted semistructured interviews (1) to identify reasons participants decided to receive or decline the vaccine for their self or child and (2) to gain feedback on messaging relevance, acceptability, and comprehensibility. This protocol was guided by the HBM [<xref ref-type="bibr" rid="ref31">31</xref>], the TRA [<xref ref-type="bibr" rid="ref30">30</xref>], and the community partner (CHEN) and CAP input. Social marketing campaign content (ie, draft messages, images/graphics) was iteratively revised using the data.</p>
        </sec>
        <sec>
          <title>Sampling and Recruitment</title>
          <p>We recruited a purposive sample of African Americans in the southeastern United States who met the following eligibility criteria: (1) adults aged 18 years or older and vaccinated or unvaccinated and (2) parents or caregivers of children aged 5-18 years and vaccinated or unvaccinated. Our community partner (CHEN) and the CAP members recruited participants via email, telephone, or word-of-mouth by using their social network and existing databases. ResearchMatch (RM), an online research recruitment tool, was also used for recruitment [<xref ref-type="bibr" rid="ref38">38</xref>].</p>
        </sec>
        <sec>
          <title>Data Collection</title>
          <p>Interested participants completed a screener. If they qualified, then they completed informed consent procedures and a brief 12-item survey on barriers to COVID-19 vaccination, with response options on a 5-point Likert-type agreement scale. The screener, consent, and demographic survey were completed via Research Electronic Data Capture (REDCap; Vanderbilt University) [<xref ref-type="bibr" rid="ref39">39</xref>], a secure web-based data collection application. Then, participants were emailed a copy of the adult and parent message sets a minimum of 3 days before the interview.</p>
          <p>Participant interviews were conducted by a trained interviewer and lasted 45-60 minutes. Open-ended scripted questions were asked using an interview guide. Questions included (1) attitudes and beliefs about COVID-19 and vaccination, (2) facilitators and barriers to COVID-19 vaccination, (3) message library content and images, and (4) dissemination strategies. For the message development section of interviews, specific questions included the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>What is your overall view and purpose of the message?</p>
            </list-item>
            <list-item>
              <p>Which parts of this message did you not understand or were not clear?</p>
            </list-item>
            <list-item>
              <p>What should be added to the message?</p>
            </list-item>
            <list-item>
              <p>What message should be removed or changed?</p>
            </list-item>
          </list>
          <p>Follow-up questions were asked for clarification and to facilitate in-depth discussion. Participants were paid a US $50 gift card. Interviews were recorded, transcribed verbatim, and de-identified for data analysis.</p>
        </sec>
        <sec>
          <title>Data Analyses</title>
          <p>Qualitative data coding and analysis was managed by the Vanderbilt University Qualitative Research Core, led by a PhD-level psychologist. Data coding and analysis were conducted following Consolidated Criteria for Reporting Qualitative Studies (COREQ) guidelines, an evidence-based qualitative methodology [<xref ref-type="bibr" rid="ref40">40</xref>]. A hierarchical coding system was developed and refined using the interview guide and a preliminary review of the transcripts. Experienced qualitative coders first established reliability in using the coding system on 2 transcripts, reconciling any discrepancies, and then independently coded the remaining transcripts. We used an iterative inductive/deductive approach to qualitative data analysis [<xref ref-type="bibr" rid="ref41">41</xref>,<xref ref-type="bibr" rid="ref42">42</xref>]. Inductively, we sorted the quotations by coding category to identify higher-order themes and relationships between themes. Deductively, we were guided by the HBM and the TRA. The transcripts, quotations, and codes were managed using Microsoft Excel 2016 and IBM SPSS Statistics version 28.0. Survey data were also analyzed using SPSS Statistics version 28.0. Descriptive analysis (eg, means, frequencies) and bivariate analysis (eg, chi-square tests, Fisher exact tests) were performed to describe patterns in the data.</p>
        </sec>
        <sec>
          <title>Message Library Revision Process</title>
          <p>Using the original message library, the research team iteratively modified the message sets and added visuals and videos to “match” the messages to increase comprehensibility and appropriateness. A subgroup of the research team met regularly to discuss interview findings and the message library, and subsequent changes were made. Then, all members of the partnership met to discuss the changes and identify additional needed modifications. Each new iteration of the messages and visuals was developed using peripheral, evidential, linguistic, and sociocultural strategies [<xref ref-type="bibr" rid="ref32">32</xref>]. A final meeting was held to ensure that all feedback was incorporated into the message library and was culturally appropriate.</p>
        </sec>
      </sec>
      <sec>
        <title>Content Validation of Messages by Experts, November 2021-January 2022</title>
        <p>Five experts were identified to review the content for accuracy and relevance. These reviews were conducted strategically due to the ever-changing nature of COVID-19 pandemic updates. Specifically, 2 experts reviewed the content prior to, 1 during, and 3 after community review. Selection criteria for these content reviewers were experience in SARS-CoV-2/COVID-19 research, including vaccination, expertise in the use of psychosocial theory, and willingness and ability to review the items.</p>
        <p>Adapted from Lawshe [<xref ref-type="bibr" rid="ref43">43</xref>], we used qualitative and quantitative methods in a 2-phase content review process. Specifically, each message subset was quantitatively evaluated for relevance by using a 3-point Likert scale: “essential,” “useful but not essential,” and “not necessary.” Then, experts reviewed the messages for perceived accuracy and clarity by providing written comments and edits for improvement. Using these methods, we iteratively refined the messages.</p>
      </sec>
      <sec>
        <title>Ethical Considerations</title>
        <p>This research was approved by Meharry Medical College’s Institutional Review Board (Protocol 21-03-1076). All participants provided oral informed consent.</p>
      </sec>
    </sec>
    <sec sec-type="results">
      <title>Results</title>
      <sec>
        <title>Community Advisory Panel Feedback</title>
        <p>The CAP members’ feedback evolved throughout the message library development process. At the beginning of each meeting, the researchers gained insight into the community’s thinking about the COVID-19 vaccine to determine trends in hesitancy. Top concerns included vaccine safety, the speed of vaccine development, mistrust in research and health care, politicization of the vaccine, and conspiracy theories (eg, tracking chip in the vaccine). We then asked about the presentation of messaging. Members suggested that messages should be concise yet comprehensible across reading levels. Members further indicated the need to discuss immediate and long-term benefits and the risks of vaccination so that the community can make an informed decision. A few members further suggested the need to use numbers and images to explain these concerns more clearly.</p>
        <p>Select members of the CAP were asked to conduct a detailed review of the messages and images to identify ways to make the content more relatable and comprehensible. Some even provided preferred sources of content (eg, NPR (National Public Radio), which is media organization that seeks to create a more informed public via air, online, or in-person) to help develop the material. Collectively, we used the feedback from the quarterly advisory panel meetings and subgroup review of messages to update the library.</p>
      </sec>
      <sec>
        <title>Semistructured Interviews</title>
        <sec>
          <title>Sociodemographics</title>
          <p>Most participants were female and had a college degree or higher. More than half had a household income less than US $80,000. The mean age was 38.6 years (SD 9.49 years). See <xref ref-type="table" rid="table1">Table 1</xref> for sociodemographics by subgroup: vaccinated adult, unvaccinated adult, adult with unvaccinated child, and adult with vaccinated child.</p>
          <table-wrap position="float" id="table1">
            <label>Table 1</label>
            <caption>
              <p>Sociodemographics of African American interview participants (N=30).</p>
            </caption>
            <table width="1000" cellpadding="5" cellspacing="0" border="1" rules="groups" frame="hsides">
              <col width="30"/>
              <col width="270"/>
              <col width="180"/>
              <col width="170"/>
              <col width="180"/>
              <col width="170"/>
              <thead>
                <tr valign="top">
                  <td colspan="2">Characteristic</td>
                  <td>Parent<sup>a</sup> with vaccinated child (N=7)</td>
                  <td>Parent with unvaccinated child (N=7)</td>
                  <td>Adult, vaccinated (N=9)</td>
                  <td>Adult, unvaccinated (N=7)</td>
                </tr>
              </thead>
              <tbody>
                <tr valign="top">
                  <td colspan="2">Age (years), mean (SD)</td>
                  <td>42.4 (6.1)</td>
                  <td>37.4 (6.2)</td>
                  <td>36.1 (12.5)</td>
                  <td>39.1 (11.1)</td>
                </tr>
                <tr valign="top">
                  <td colspan="6">
                    <bold>Gender, n (%)</bold>
                  </td>
                </tr>
                <tr valign="top">
                  <td>
                    <break/>
                  </td>
                  <td>Male</td>
                  <td>2 (29)</td>
                  <td>1 (14)</td>
                  <td>2 (22)</td>
                  <td>1 (14)</td>
                </tr>
                <tr valign="top">
                  <td>
                    <break/>
                  </td>
                  <td>Female</td>
                  <td>5 (71)</td>
                  <td>6 (86)</td>
                  <td>7 (78)</td>
                  <td>6 (86)</td>
                </tr>
                <tr valign="top">
                  <td colspan="6">
                    <bold>Education, n (%)</bold>
                  </td>
                </tr>
                <tr valign="top">
                  <td>
                    <break/>
                  </td>
                  <td>Some college or lower</td>
                  <td>2 (29)</td>
                  <td>2 (29)</td>
                  <td>2 (22)</td>
                  <td>1 (14)</td>
                </tr>
                <tr valign="top">
                  <td>
                    <break/>
                  </td>
                  <td>College degree or higher</td>
                  <td>5 (71)</td>
                  <td>5 (71)</td>
                  <td>7 (78)</td>
                  <td>6 (86)</td>
                </tr>
                <tr valign="top">
                  <td colspan="6">
                    <bold>Household income (US $), n (%)</bold>
                  </td>
                </tr>
                <tr valign="top">
                  <td>
                    <break/>
                  </td>
                  <td>≤40,000</td>
                  <td>2 (29)</td>
                  <td>2 (29)</td>
                  <td>2 (22)</td>
                  <td>3 (42)</td>
                </tr>
                <tr valign="top">
                  <td>
                    <break/>
                  </td>
                  <td>40,001-80,000</td>
                  <td>2 (29)</td>
                  <td>0</td>
                  <td>2 (22)</td>
                  <td>2 (29)</td>
                </tr>
                <tr valign="top">
                  <td>
                    <break/>
                  </td>
                  <td>&#62;80,000</td>
                  <td>3 (42)</td>
                  <td>4 (57)</td>
                  <td>3 (34)</td>
                  <td>0</td>
                </tr>
                <tr valign="top">
                  <td>
                    <break/>
                  </td>
                  <td>Not available</td>
                  <td>0</td>
                  <td>1 (14)</td>
                  <td>2 (22)</td>
                  <td>2 (29)</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="table1fn1">
                <p><sup>a</sup>Parents had children aged 5-18 years.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
        <sec>
          <title>Summary of Findings</title>
          <p>Using the inductive-deductive approach, we identified 4 primary themes specific to the development of messages related to COVID-19 and the vaccines in the qualitative study. Messages were referenced in the text by the theme and message number (eg, 1.01 is the first quotation related to theme 1). See <xref ref-type="supplementary-material" rid="app2">Multimedia Appendix 2</xref> for quotations related to each theme.</p>
        </sec>
        <sec>
          <title>Theme 1: Community Reactions to the Messages</title>
          <p>Overall, the community members found that the messages were “very helpful” and had a “community feel.” Specifically, the messages were inclusive and comprehensive and had a good balance between science and simple language. The messages were viewed as “good,” “persuasive” (quotation 1.02), and “educational” (quotations 1.01-1.02). Most participants stated that the reading level was good, and suggested a few edits to specific messages (eg, whether the messenger RNA [mRNA] vaccine changes your DNA). Although there were mixed reviews, most perceived the length and number of messages in each set to be appropriate.</p>
          <p>For message presentation, many perceived that there were good analogies and comparisons to increase comprehension (quotation 1.03). If applicable to the message set, participants liked the balance of benefits and risks of vaccines. Lastly, a few participants cited the messages as relatable, trustworthy, and credible. Collectively, participants perceived that the information helped guide decision-making and did not simply “tell you” to take the vaccine.</p>
        </sec>
        <sec>
          <title>Theme 2: Questions and Information Needs</title>
          <p>Some participants had questions after reviewing the messages. A participant wanted to know where specific evidence for the general numbers on some websites (eg, the Centers for Disease Control and Prevention [<xref ref-type="bibr" rid="ref44">44</xref>]) could be found. Other questions were related to long-term effects of the vaccine, “why we even need the vaccine,” mixing vaccines and boosters, or the number of boosters after the first dose (quotation 2.01). Others asked about the relationship of COVID-19 vaccines and fertility. Lastly, participants asked how existing conditions (eg, diabetes, asthma) were related to the severity of COVID-19.</p>
        </sec>
        <sec>
          <title>Theme 3: Suggestions for Additional Content</title>
          <p>Most participants had suggestions for additional content or context for specific message sets. A suggestion for overall messages was to add a statement that science evolves as more data are collected to communicate new findings, which are constantly being added to increase our knowledge of COVID-19. For vaccine safety, additional information was requested on mRNA, along with the 30-year history of studies of mRNA and its use in vaccines (quotation 3.01). Participants asked for more information on the clinical trial process and better justification for boosters and their side effects. As it relates to vaccines and infertility, a suggestion was made to provide recommendations from gynecology professionals and experts and information about long-term effects of COVID-19 vaccines on infertility. Lastly, a few participants wanted to know whether the vaccines can lead to sexual dysfunction (quotation 3.02).</p>
          <p>Distrusting in the government and pharmaceutical companies, participants wanted more details about the COVID vaccines (ie, development, testing, and ingredients; quotation 3.03). For vaccine effectiveness, participants asked about healthy people getting the virus and how outcomes of the vaccinated compare to those of the unvaccinated (quotation 3.04). They also asked why natural immunity is not better than vaccine-induced immunity. Participants wanted more information on variants (eg, Omicron), their severity, and how variants affect vaccine effectiveness.</p>
          <p>For children specifically, participants asked for data on successes and challenges during development (quotation 3.05), along with updates on vaccine safety. Participants also suggested reinforcing other preventive behaviors, such as sanitizing, healthy eating, and physical distancing (quotation 3.06). Some further wanted to know alternative ways to boost their immune system without taking a vaccine or booster (quotations 3.07 and 3.08). A few suggested the need to encourage conversations with doctors, especially for those with underlying medical conditions, prior to getting the vaccine.</p>
        </sec>
        <sec>
          <title>Theme 4: Suggestions to Increase Comprehension, Relevance, and Trustworthiness</title>
          <p>A few suggestions were made to enhance comprehension. One suggestion was to provide definitions for specific terms (eg, high risk; quotation 4.01). Providing an easier-to-understand presentation of statistics was commonly mentioned. For example, participants further suggested the “need for statistics or more data” to help understand the vaccine development process. Participants emphasized the importance of clarifying the magnitude of potential side effects. Visuals were suggested to improve understandability of messages. Participants also suggested the use of specific terms such as “vaccination” and not “shot.” Lastly, 1 (3%) participant suggested having information available in other languages (eg, Arabic).</p>
          <p>A few participants indicated the need for messages to be tied to things people already understand, such as flu or smallpox vaccines, to increase relevance. Other suggestions were to use videos and images to reflect content. Some participants also wanted videos of personal testimonies of individuals who were undecided about the vaccine and their decision-making process to get vaccinated (quotation 4.02). Notably, testimonials were also perceived by others to be too contrived (quotation 4.03). To increase trustworthiness, participants suggested providing proof that doctors or health professionals (quotation 4.04) supported this work, along with the addition of informational sources, especially links to studies that provide supportive evidence. Lastly, participants encouraged honesty and transparency in information related to the COVID-19 vaccines.</p>
        </sec>
      </sec>
      <sec>
        <title>Content Validation</title>
        <p>In total, 6 reviewers validated the content. Of these 6, 2 (33%) were White Americans, and 4 (67%) were African Americans; 4 (67%) were female, and 2 (33%) were male. In addition, 1 (17%) reviewer provided feedback for only adult concerns. Reviewers’ areas of expertise included vaccine development, immunology, vaccine-preventable disease and immunizations, and nurse safety. Messages were iteratively updated based on feedback of experts. Most message subsets were classified as essential or useful but not essential. Content edits and additions to the message library reflected the updates on the coronavirus and the vaccine and strategies to ensure comprehensibility and accuracy. Reordering, rephrasing, and adding (eg, analogies) of content were conducted to increase clarity. Because updates are ongoing for COVID-19, content was deemed evidential once primary concepts (eg, process of vaccine development or purpose of boosters) were validated, with the intent to continue to update the library with expert review.</p>
      </sec>
      <sec>
        <title>Reading Grade Level Assessment</title>
        <p>To finalize the library messages, a readability assessment was conducted. We used 3 primary reading grade level assessment tools and an online consensus tool to assess the reading grade level of the adult and parent message sets. First, the Flesch Reading Ease Score [<xref ref-type="bibr" rid="ref45">45</xref>] was calculated in Microsoft Word. Higher scores indicate easier readability by the user. Second, the Flesch-Kincaid Grade Level [<xref ref-type="bibr" rid="ref46">46</xref>] was calculated in Microsoft Word to determine a US school grade level. The Flesch Reading Ease and Flesch-Kincaid Grade Levels are calculated by considering the average sentence length (total number of words divided by total number of sentences) and the average syllables per word (total number of syllables divided by the total number of words) using different underlying formulas. Third, the Simple Measure of Gobbledygook (SMOG) index was hand-scored, in addition to being automatically calculated to determine a US [<xref ref-type="bibr" rid="ref47">47</xref>] school grade level. The SMOG index is calculated using the number of words with multiple syllables in three 10-sentence samples at the beginning, middle, and end of the text. These 3 readability assessment tools all use word difficulty and sentence length as the main factors in determining how easy or how hard the material is to read. Finally, an online readability calculator [<xref ref-type="bibr" rid="ref48">48</xref>] was used to determine readability consensus. The online calculator applied 7 commonly used readability formulas to provide a consensus rating. See <xref ref-type="table" rid="table2">Table 2</xref> for readability assessment results.</p>
        <p>The readability assessment revealed acceptable reading grade level scores for all readability formulas applied. The usual recommended reading grade level is fifth-sixth grade to optimize comprehension, according to the American Medical Association and the United States Department of Health and Human Services. However, in combination with the iterative development process and ongoing review by the community partner (CHEN), the CAP, and experts, the messages reflected use of plain language when polysyllabic or complex words were unavoidable.</p>
        <table-wrap position="float" id="table2">
          <label>Table 2</label>
          <caption>
            <p>Reading grade level results.</p>
          </caption>
          <table width="1000" cellpadding="5" cellspacing="0" border="1" rules="groups" frame="hsides">
            <col width="280"/>
            <col width="360"/>
            <col width="360"/>
            <thead>
              <tr valign="top">
                <td>Readability assessment tool</td>
                <td>Adult library</td>
                <td>Parent library</td>
              </tr>
            </thead>
            <tbody>
              <tr valign="top">
                <td>Flesch Reading Ease Score</td>
                <td>62.0 (standard/average)</td>
                <td>62.5 (standard/average)</td>
              </tr>
              <tr valign="top">
                <td>Flesch-Kincaid Grade Level</td>
                <td>8.4 (8th grade)</td>
                <td>8.3 (8th grade)</td>
              </tr>
              <tr valign="top">
                <td>SMOG<sup>a</sup> index</td>
                <td>7.7 (8th grade)</td>
                <td>7.6 (8th grade)</td>
              </tr>
              <tr valign="top">
                <td>Readability consensus<sup>b</sup></td>
                <td>
                  <list list-type="bullet">
                    <list-item>
                      <p>Grade level: 8</p>
                    </list-item>
                    <list-item>
                      <p>Reading level: standard/average</p>
                    </list-item>
                    <list-item>
                      <p>Age of reader: 12-14 years (7th-8th grade)</p>
                    </list-item>
                  </list>
                </td>
                <td>
                  <list list-type="bullet">
                    <list-item>
                      <p>Grade level: 8</p>
                    </list-item>
                    <list-item>
                      <p>Reading level: standard/average</p>
                    </list-item>
                    <list-item>
                      <p>Age of reader: 12-14 years (7th-8th grade)</p>
                    </list-item>
                  </list>
                </td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="table2fn1">
              <p><sup>a</sup>SMOG: Simple Measure of Gobbledygook.</p>
            </fn>
            <fn id="table2fn2">
              <p><sup>b</sup>Readability consensus was based on the application of 7 readability formulas using an online calculator available [<xref ref-type="bibr" rid="ref44">44</xref>].</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec>
        <title>Message Set Finalization</title>
        <p>After completion of the readability assessment, members of the research team conducted a final review to ensure comprehensibility and accuracy. Minor edits were made. See <xref ref-type="table" rid="table3">Table 3</xref> for an example of a concern, along with an example of a message for the concern after the adaptation process.</p>
        <table-wrap position="float" id="table3">
          <label>Table 3</label>
          <caption>
            <p>Example of a message for tailoring a variable postiterative development process.</p>
          </caption>
          <table width="1000" cellpadding="5" cellspacing="0" border="1" rules="groups" frame="hsides">
            <col width="30"/>
            <col width="300"/>
            <col width="0"/>
            <col width="670"/>
            <thead>
              <tr valign="top">
                <td colspan="3">Vaccine concern</td>
                <td>Example message</td>
              </tr>
            </thead>
            <tbody>
              <tr valign="top">
                <td colspan="4">
                  <bold>Category 1: vaccine development</bold>
                </td>
              </tr>
              <tr valign="top">
                <td>
                  <break/>
                </td>
                <td>“Human protections in research” [adult and parent]</td>
                <td colspan="2">Many people wonder about taking part in research and if they will be protected. We know there have been past research studies that were not done right [provides examples of historical research abuses]. To begin to address this issue, we give a few examples to show every person is protected when they take part in research and how the community could benefit after the research study is done [provides examples of human protections in research].</td>
              </tr>
              <tr valign="top">
                <td>
                  <break/>
                </td>
                <td>“Who is at the table?” [Adult and parent]</td>
                <td colspan="2">Many people wonder if people of all racial backgrounds were involved when the vaccines were developed. Individuals from all races were at the table to help guide the process [provides examples of scientists of all racial/ethnic backgrounds and their role in the development process].</td>
              </tr>
              <tr valign="top">
                <td colspan="4">
                  <bold>Category 2: vaccine safety</bold>
                </td>
              </tr>
              <tr valign="top">
                <td>
                  <break/>
                </td>
                <td>“mRNA<sup>a</sup> and DNA” [adult]</td>
                <td colspan="2">We all have mRNA in every cell in our bodies. mRNA is known as messenger RNA. It is the “recipe” that tells the cells in our body to make certain proteins. The mRNA protein in the Pfizer and Moderna COVID-19 vaccines shows up, teaches the immune system how to develop antibodies against SARS-CoV-2 (the virus that causes COVID-19), and then quickly dissolves. mRNA never enters the nucleus of the cell where your DNA is kept. Your body learns how to protect itself against future SARS-CoV-2 infection without ever having to risk getting the virus or the serious outcomes of getting sick with COVID-19.</td>
              </tr>
              <tr valign="top">
                <td>
                  <break/>
                </td>
                <td>“Infertility” [adult]</td>
                <td colspan="2">The antibody to the spike protein does not make a woman infertile or unable to get pregnant. There was a false claim that there were similarities between the SARS-CoV-2 spike protein and the surface of a protein on placental cells. Placental cells are needed for a successful pregnancy. SARS-CoV-2 spike protein and the placental cells are not the same. This means the vaccine will not cause the immune system to make antibodies against the placental protein.</td>
              </tr>
              <tr valign="top">
                <td>
                  <break/>
                </td>
                <td>“Your child’s heart” [parent]</td>
                <td colspan="2">Many parents ask about the COVID-19 vaccine and how it can affect the hearts of children. In the United States, there has been an increase in myocarditis and pericarditis cases after getting the mRNA COVID-19 vaccine. Myocarditis is mild inflammation of the heart. Pericarditis is mild inflammation of the sack around the heart. For children under 16 years of age, myocarditis risk is 37 times higher for children with COVID-19 than the children without COVID-19. So, myocarditis does not happen often. The American Academy of Pediatrics says children and teens should get the COVID-19 vaccines.</td>
              </tr>
              <tr valign="top">
                <td>
                  <break/>
                </td>
                <td>“My child has underlying medical conditions.” [Parent]</td>
                <td colspan="2">The Pfizer vaccine can be given to children 5 [years] and older with underlying medical conditions like diabetes or autoimmune diseases. It cannot cause COVID-19, even in those with weak immune systems. Children with underlying medical conditions took part in the clinical trials and serious reactions to the vaccine [were] rare. However, children with underlying medical conditions are more apt to have problems from COVID-19.</td>
              </tr>
              <tr valign="top">
                <td colspan="4">
                  <bold>Category 3: vaccine effectiveness</bold>
                </td>
              </tr>
              <tr valign="top">
                <td>
                  <break/>
                </td>
                <td>“Boosters. Why?” [Adult]</td>
                <td colspan="2">All routine [vaccines] require booster doses to have full protection [adds examples]. So the COVID-19 vaccine is not any different. Booster shots are given to jumpstart the body’s immune system to produce more antibodies against the original SARS-CoV-2 (the virus that causes COVID-19) and help protect against new variants. Because antibody levels decrease over time, boosters are needed to keep us protected.</td>
              </tr>
              <tr valign="top">
                <td>
                  <break/>
                </td>
                <td>“Variants and the vaccine” [adult]</td>
                <td colspan="2">As SARS-CoV-2 (the virus that causes COVID-19) continues to infect people, it is more likely to mutate. This means that the virus makes a new version of itself also known as a mutation. It is common for this to happen. Mutations affect how viruses work, like to help the virus better attach to our cells or lower the virus’s ability to attach to our cells. So it is important for people to complete COVID-19 vaccination. More mutations and new variants may lower or stop the protection provided by the vaccines.</td>
              </tr>
              <tr valign="top">
                <td>
                  <break/>
                </td>
                <td>“Natural immunity or vaccine immunity”</td>
                <td colspan="2">Natural immunity happens when your child’s body gets infected with the SARS-CoV-2 virus, the virus that causes COVID-19. While your child’s body will make antibodies against the virus, the danger is in your child getting very sick and maybe even dying. Immunity from getting a vaccine is very similar to immunity developed through natural infection but does not carry the increased risk of your child getting very sick or even death. Natural immunity provides less protection over time than the immunity gained by COVID-19. While people can gain immunity after getting the virus, studies show that more than one third of COVID-19 infections results in low levels of protective antibodies.</td>
              </tr>
              <tr valign="top">
                <td>
                  <break/>
                </td>
                <td>“Too many vaccines” [parent]</td>
                <td colspan="2">We all got different vaccines when we were babies, adolescents, and event adults [gives an example of multiple vaccines being given]. These vaccines are routinely given at the same time without serious side effects. So, getting more than one vaccine is something we have been doing since birth.</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="table3fn1">
              <p><sup>a</sup>mRNA: messenger RNA.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec>
        <title>Final Message Library</title>
        <p>The final message library had 2 message sets, 1 for adults and 1 for parents. There were 18 message subsets for adults and 17 message subsets for parents. These subsets were placed into 3 categories: vaccine development, vaccine safety, and vaccine effectiveness. Each message subset begins with expressing empathy toward the individuals’ concern. Then the facts are provided around each concern, positive or negative. Lastly, the message subset ends with a positive statement related to COVID-19 vaccination that addresses concerns. All message subsets were reviewed by community leaders and members (constituent-involving strategy). We briefly describe each subset for each group next. Each message subset was presented using 3 modes: content, image, and video. See <xref ref-type="table" rid="table4">Table 4</xref> to identify each concern, along with key message attributes and the associated strategy to achieve cultural appropriateness.</p>
        <table-wrap position="float" id="table4">
          <label>Table 4</label>
          <caption>
            <p>Vaccine concern, key message attributes, types of visuals, and type of cultural targeting strategy.</p>
          </caption>
          <table width="1000" cellpadding="5" cellspacing="0" border="1" rules="groups" frame="hsides">
            <col width="30"/>
            <col width="170"/>
            <col width="0"/>
            <col width="350"/>
            <col width="0"/>
            <col width="270"/>
            <col width="0"/>
            <col width="180"/>
            <thead>
              <tr valign="bottom">
                <td colspan="3">Vaccine concern<sup>a</sup></td>
                <td colspan="2">Key message attributes</td>
                <td colspan="2">Types of visuals</td>
                <td>Cultural targeting<break/>strategy</td>
              </tr>
            </thead>
            <tbody>
              <tr valign="top">
                <td colspan="8">
                  <bold>Vaccine development</bold>
                </td>
              </tr>
              <tr valign="top">
                <td>
                  <break/>
                </td>
                <td>Human protections in research</td>
                <td colspan="2">
                  <list list-type="bullet">
                    <list-item>
                      <p>Acknowledge historical research abuses (eg, U.S. Public Health Service Syphilis Study, Henrietta Lacks).</p>
                    </list-item>
                    <list-item>
                      <p>Provide examples of protections provided in research.</p>
                    </list-item>
                    <list-item>
                      <p>Discuss how the community can be involved in the research process (eg, co–primary investigator, community advisory board, consultant).</p>
                    </list-item>
                  </list>
                </td>
                <td colspan="2">
                  <list list-type="bullet">
                    <list-item>
                      <p>Not applicable</p>
                    </list-item>
                  </list>
                </td>
                <td colspan="2">Sociocultural, evidential</td>
              </tr>
              <tr valign="top">
                <td>
                  <break/>
                </td>
                <td>Who is at the table?</td>
                <td colspan="2">
                  <list list-type="bullet">
                    <list-item>
                      <p>Discuss researchers (ie, current job, expertise) across all backgrounds and their role in the development process.</p>
                    </list-item>
                    <list-item>
                      <p>List their current jobs.</p>
                    </list-item>
                  </list>
                </td>
                <td colspan="2">
                  <list list-type="bullet">
                    <list-item>
                      <p>Researchers of diverse backgrounds (visual)</p>
                    </list-item>
                    <list-item>
                      <p>Researcher describing role in vaccine development (video)</p>
                    </list-item>
                  </list>
                </td>
                <td colspan="2">Sociocultural, evidential, peripheral</td>
              </tr>
              <tr valign="top">
                <td>
                  <break/>
                </td>
                <td>Too new and too quick</td>
                <td colspan="2">
                  <list list-type="bullet">
                    <list-item>
                      <p>Define mRNA<sup>b</sup> and its role in the body.</p>
                    </list-item>
                    <list-item>
                      <p>Discuss the mRNA vaccine history and how it works in the body.</p>
                    </list-item>
                    <list-item>
                      <p>Define what mRNA does not do (change DNA).</p>
                    </list-item>
                    <list-item>
                      <p>Compare mRNA vaccine development to existing vaccine development processes.</p>
                    </list-item>
                    <list-item>
                      <p>Define the EUA<sup>c</sup>.</p>
                    </list-item>
                    <list-item>
                      <p>Discuss the number of vaccines given to date, adverse events, and how to identify those events.</p>
                    </list-item>
                    <list-item>
                      <p>Confirm that being unvaccinated places one at higher risk of death compared to those who received the vaccine.</p>
                    </list-item>
                  </list>
                </td>
                <td colspan="2">
                  <list list-type="bullet">
                    <list-item>
                      <p>Timeline of COVID-19 vaccine development (visual and video)</p>
                    </list-item>
                  </list>
                </td>
                <td colspan="2">Evidential, peripheral</td>
              </tr>
              <tr valign="top">
                <td>
                  <break/>
                </td>
                <td>How research works</td>
                <td colspan="2">
                  <list list-type="bullet">
                    <list-item>
                      <p>Define research.</p>
                    </list-item>
                    <list-item>
                      <p>Define clinical trials and their phases.</p>
                    </list-item>
                    <list-item>
                      <p>Define types of researchers.</p>
                    </list-item>
                    <list-item>
                      <p>Define sites of research and who can participate.</p>
                    </list-item>
                    <list-item>
                      <p>Discuss what happens after research.</p>
                    </list-item>
                  </list>
                </td>
                <td colspan="2">
                  <list list-type="bullet">
                    <list-item>
                      <p>Demonstration of phases in the clinical process and steps within each phase (visual)</p>
                    </list-item>
                  </list>
                </td>
                <td colspan="2">Evidential, peripheral</td>
              </tr>
              <tr valign="top">
                <td colspan="8">
                  <bold>Vaccine safety</bold>
                </td>
              </tr>
              <tr valign="top">
                <td>
                  <break/>
                </td>
                <td>mRNA and DNA</td>
                <td colspan="2">
                  <list list-type="bullet">
                    <list-item>
                      <p>State years of mRNA existence and mRNA’s role in the body.</p>
                    </list-item>
                    <list-item>
                      <p>Explain the process of mRNA technology.</p>
                    </list-item>
                    <list-item>
                      <p>Identify vaccines that use mRNA technology.</p>
                    </list-item>
                    <list-item>
                      <p>Emphasize benefits of vaccination over natural immunity.</p>
                    </list-item>
                  </list>
                </td>
                <td colspan="2">
                  <list list-type="bullet">
                    <list-item>
                      <p>Demonstration of the mRNA technology process (visual and video)</p>
                    </list-item>
                  </list>
                </td>
                <td colspan="2">Evidential, peripheral, linguistic</td>
              </tr>
              <tr valign="top">
                <td>
                  <break/>
                </td>
                <td>Infertility</td>
                <td colspan="2">
                  <list list-type="bullet">
                    <list-item>
                      <p>Demonstrate how the proteins needed for pregnancy and needed to make the spike protein are not the same.</p>
                    </list-item>
                    <list-item>
                      <p>Emphasize that women are able to conceive, have a healthy pregnancy and baby, and breastfeed after vaccination.</p>
                    </list-item>
                    <list-item>
                      <p>State that babies receive antibodies from vaccinated mothers.</p>
                    </list-item>
                    <list-item>
                      <p>Highlight that COVID-19 may impact fertility in men.</p>
                    </list-item>
                    <list-item>
                      <p>Highlight cons of nonvaccination in pregnant women (eg, increased risk of stillbirth, newborn deaths, hospitalization).</p>
                    </list-item>
                  </list>
                </td>
                <td colspan="2">
                  <list list-type="bullet">
                    <list-item>
                      <p>Explanation of pregnant women getting the vaccine or women conceiving getting vaccinated (video)</p>
                    </list-item>
                  </list>
                </td>
                <td colspan="2">Evidential, linguistic</td>
              </tr>
              <tr valign="top">
                <td>
                  <break/>
                </td>
                <td>Underlying medical conditions</td>
                <td colspan="2">
                  <list list-type="bullet">
                    <list-item>
                      <p>State the reason to vaccinate with an underlying condition.</p>
                    </list-item>
                    <list-item>
                      <p>State that the vaccine will not give an individual COVID-19.</p>
                    </list-item>
                    <list-item>
                      <p>Discuss the vaccine schedule for those immunocompromised.</p>
                    </list-item>
                    <list-item>
                      <p>Discuss the severity in COVID-19 if not vaccinated.</p>
                    </list-item>
                  </list>
                  <list list-type="bullet">
                    <list-item>
                      <p>State to consult with a doctor in getting the vaccine.</p>
                    </list-item>
                  </list>
                </td>
                <td colspan="2">
                  <list list-type="bullet">
                    <list-item>
                      <p>Explanation of why those with underlying medical conditions need the vaccine (video)</p>
                    </list-item>
                  </list>
                </td>
                <td colspan="2">Evidential, linguistic</td>
              </tr>
              <tr valign="top">
                <td>
                  <break/>
                </td>
                <td>Your heart</td>
                <td colspan="2">
                  <list list-type="bullet">
                    <list-item>
                      <p>Define myocarditis and pericarditis.</p>
                    </list-item>
                    <list-item>
                      <p>Compare the rate of heart problems in those who get vaccinated compared to those who get COVID-19.</p>
                    </list-item>
                    <list-item>
                      <p>Demonstrate the symptoms and treatment of heart disorders.</p>
                    </list-item>
                    <list-item>
                      <p>Emphasize the recommendation by infectious disease experts and the American Academy of Pediatrics for children.</p>
                    </list-item>
                  </list>
                </td>
                <td colspan="2">
                  <list list-type="bullet">
                    <list-item>
                      <p>Explanation of myocarditis and vaccination (video)</p>
                    </list-item>
                  </list>
                </td>
                <td colspan="2">Evidential, linguistic</td>
              </tr>
              <tr valign="top">
                <td>
                  <break/>
                </td>
                <td>GBS<sup>d</sup> (adult only)</td>
                <td colspan="2">
                  <list list-type="bullet">
                    <list-item>
                      <p>Define GBS.</p>
                    </list-item>
                    <list-item>
                      <p>Discuss the signs of GBS.</p>
                    </list-item>
                    <list-item>
                      <p>Discuss the number of cases to date after vaccination.</p>
                    </list-item>
                    <list-item>
                      <p>Emphasize that it is rare.</p>
                    </list-item>
                  </list>
                </td>
                <td colspan="2">
                  <list list-type="bullet">
                    <list-item>
                      <p>Not applicable</p>
                    </list-item>
                  </list>
                </td>
                <td colspan="2">Evidential, linguistic</td>
              </tr>
              <tr valign="top">
                <td>
                  <break/>
                </td>
                <td>Blood clots (adult only)</td>
                <td colspan="2">
                  <list list-type="bullet">
                    <list-item>
                      <p>Identify the number of cases with the Johnson &#38; Johnson vaccine.</p>
                    </list-item>
                    <list-item>
                      <p>Discuss why the Food and Drug Administration (FDA) halted the clinical trial to determine whether risks of blood clots outweigh the benefits of the vaccine.</p>
                    </list-item>
                    <list-item>
                      <p>State recommendation of Moderna and Pfizer vaccines over the Johnson &#38; Johnson vaccine.</p>
                    </list-item>
                    <list-item>
                      <p>Discuss the symptoms of blood clots.</p>
                    </list-item>
                  </list>
                  <list list-type="bullet">
                    <list-item>
                      <p>State the blood clot risk for those vaccinated and unvaccinated.</p>
                    </list-item>
                  </list>
                </td>
                <td colspan="2">
                  <list list-type="bullet">
                    <list-item>
                      <p>Symptoms of blood clots vs symptoms of COVID-19 (visual)</p>
                    </list-item>
                  </list>
                </td>
                <td colspan="2">Peripheral, evidential, linguistic</td>
              </tr>
              <tr valign="top">
                <td>
                  <break/>
                </td>
                <td>Side effects</td>
                <td colspan="2">
                  <list list-type="bullet">
                    <list-item>
                      <p>Emphasize the number of years for COVID-19 research.</p>
                    </list-item>
                    <list-item>
                      <p>Discuss the number of lives and hospitalizations prevented with vaccines.</p>
                    </list-item>
                    <list-item>
                      <p>Identify the risk of allergic reactions and short-term side effects.</p>
                    </list-item>
                    <list-item>
                      <p>Discuss that side effects are short-lived and everyone reacts differently.</p>
                    </list-item>
                    <list-item>
                      <p>State that routine vaccinations show no long-term side effects.</p>
                    </list-item>
                  </list>
                </td>
                <td colspan="2">
                  <list list-type="bullet">
                    <list-item>
                      <p>Side effects of vaccination compared to natural infection through SARS-CoV-2 (visual and video)</p>
                    </list-item>
                  </list>
                </td>
                <td colspan="2">Peripheral, evidential, linguistic</td>
              </tr>
              <tr valign="top">
                <td>
                  <break/>
                </td>
                <td>Too young (parent only)</td>
                <td colspan="2">
                  <list list-type="bullet">
                    <list-item>
                      <p>Emphasize the impact of COVID-19 on children.</p>
                    </list-item>
                    <list-item>
                      <p>Provide recommendations for COVID-19 vaccination by age.</p>
                    </list-item>
                    <list-item>
                      <p>Emphasize that vaccination protects them and others.</p>
                    </list-item>
                    <list-item>
                      <p>State that the long-term effects of COVID-19 in children are unknown, but long COVID is seen in many.</p>
                    </list-item>
                  </list>
                </td>
                <td colspan="2">
                  <list list-type="bullet">
                    <list-item>
                      <p>Statistics of current COVID-19 cases in children and increases in COVID-19 cases, hospitalizations, and deaths in children overtime (visual)</p>
                    </list-item>
                  </list>
                </td>
                <td colspan="2">Evidential, peripheral, linguistic</td>
              </tr>
              <tr valign="top">
                <td colspan="8">
                  <bold>Vaccine effectiveness</bold>
                </td>
              </tr>
              <tr valign="top">
                <td>
                  <break/>
                </td>
                <td>Unsure if it works</td>
                <td colspan="2">
                  <list list-type="bullet">
                    <list-item>
                      <p>Define effectiveness and how to obtain it (ie, fully vaccinated).</p>
                    </list-item>
                    <list-item>
                      <p>Demonstrate risks if not vaccinated.</p>
                    </list-item>
                  </list>
                </td>
                <td colspan="2">
                  <list list-type="bullet">
                    <list-item>
                      <p>Comparison of risk of hospitalization and death of those vaccinated vs not vaccinated (visual)</p>
                    </list-item>
                  </list>
                </td>
                <td colspan="2">Peripheral, evidential, linguistic</td>
              </tr>
              <tr valign="top">
                <td>
                  <break/>
                </td>
                <td>Variants</td>
                <td colspan="2">
                  <list list-type="bullet">
                    <list-item>
                      <p>Define “breakthrough case.”</p>
                    </list-item>
                    <list-item>
                      <p>Discuss mutations and how new variants are created.</p>
                    </list-item>
                    <list-item>
                      <p>Discuss the impact of emerging variants on vaccines and health.</p>
                    </list-item>
                    <list-item>
                      <p>Emphasize the impact of virus on short- and long-term health.</p>
                    </list-item>
                  </list>
                </td>
                <td colspan="2">
                  <list list-type="bullet">
                    <list-item>
                      <p>Not applicable</p>
                    </list-item>
                  </list>
                </td>
                <td colspan="2">Evidential, linguistic</td>
              </tr>
              <tr valign="top">
                <td>
                  <break/>
                </td>
                <td>Natural immunity</td>
                <td colspan="2">
                  <list list-type="bullet">
                    <list-item>
                      <p>Define natural immunity versus vaccine-induced immunity.</p>
                    </list-item>
                    <list-item>
                      <p>Emphasize vaccine-induced immunity being much safer than natural immunity.</p>
                    </list-item>
                    <list-item>
                      <p>Discuss the “gamble” in natural immunity over vaccine-induced immunity.</p>
                    </list-item>
                    <list-item>
                      <p>Discuss the benefits of vaccination despite having COVID-19.</p>
                    </list-item>
                  </list>
                </td>
                <td colspan="2">
                  <list list-type="bullet">
                    <list-item>
                      <p>Comparison of the health risks of those with natural immunity and those vaccinated (visual and video)</p>
                    </list-item>
                  </list>
                </td>
                <td colspan="2">Peripheral, evidential, linguistic</td>
              </tr>
              <tr valign="top">
                <td>
                  <break/>
                </td>
                <td>Too many vaccines</td>
                <td colspan="2">
                  <list list-type="bullet">
                    <list-item>
                      <p>Discuss the lack of danger of multiple vaccines at a time.</p>
                    </list-item>
                    <list-item>
                      <p>Remind people of receiving many vaccines at once as a baby and preteen.</p>
                    </list-item>
                    <list-item>
                      <p>Compare the number of proteins in the vaccine to the number of proteins if exposed to SARS-CoV-2.</p>
                    </list-item>
                  </list>
                </td>
                <td colspan="2">
                  <list list-type="bullet">
                    <list-item>
                      <p>Not applicable</p>
                    </list-item>
                  </list>
                </td>
                <td colspan="2">Evidential, linguistic</td>
              </tr>
              <tr valign="top">
                <td>
                  <break/>
                </td>
                <td>Boosters. Why?</td>
                <td colspan="2">
                  <list list-type="bullet">
                    <list-item>
                      <p>Define boosters and why they are needed.</p>
                    </list-item>
                    <list-item>
                      <p>Discuss booster recommendations.</p>
                    </list-item>
                    <list-item>
                      <p>Emphasize discussing getting a booster with a provider.</p>
                    </list-item>
                  </list>
                </td>
                <td colspan="2">
                  <list list-type="bullet">
                    <list-item>
                      <p>Stating the vaccine dose and booster schedule of each vaccine (image)</p>
                    </list-item>
                    <list-item>
                      <p>Defining a booster and why we need it (video)</p>
                    </list-item>
                  </list>
                </td>
                <td colspan="2">Evidential, peripheral, linguistic</td>
              </tr>
              <tr valign="top">
                <td>
                  <break/>
                </td>
                <td>Is it even needed?</td>
                <td colspan="2">
                  <list list-type="bullet">
                    <list-item>
                      <p>Discuss transmission routes and rates by variant.</p>
                    </list-item>
                    <list-item>
                      <p>Compare COVID-19 hospitalization, long COVID, and death rates among those vaccinated and unvaccinated.</p>
                    </list-item>
                    <list-item>
                      <p>Discuss the susceptibility and severity of COVID-19 and the importance of vaccination.</p>
                    </list-item>
                  </list>
                </td>
                <td colspan="2">
                  <list list-type="bullet">
                    <list-item>
                      <p>Tracker of COVID-19 rates and deaths (United States and Tennessee)</p>
                    </list-item>
                  </list>
                </td>
                <td colspan="2">Evidential, peripheral, linguistic</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="table4fn1">
              <p><sup>a</sup>All vaccine concerns were vetted by community leaders and members (ie, constituent-involving strategy) and edited to be comprehendible (ie, linguistics).</p>
            </fn>
            <fn id="table4fn2">
              <p><sup>b</sup>mRNA: messenger RNA.</p>
            </fn>
            <fn id="table4fn3">
              <p><sup>c</sup>EAU: emergency use authorization.</p>
            </fn>
            <fn id="table4fn4">
              <p><sup>d</sup>GBS: Guillain-Barré syndrome.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <sec>
          <title>Vaccine Development</title>
          <p>These message subsets target individuals who have concerns about the COVID-19 vaccines and the development process. The goal is to positively influence attitudes toward researchers and the process. There are 4 message sets in this category:</p>
          <list list-type="bullet">
            <list-item>
              <p>Human protections in research/child protections in research</p>
            </list-item>
            <list-item>
              <p>Who is at the table?</p>
            </list-item>
            <list-item>
              <p>Too new and too quick</p>
            </list-item>
            <list-item>
              <p>How research works</p>
            </list-item>
          </list>
        </sec>
        <sec>
          <title>Vaccine Safety</title>
          <p>These message subsets target individuals who have concerns about the safety of the COVID-19 vaccines. The goal is to demonstrate that the benefits of COVID-19 vaccination outweigh the harms of COVID-19 vaccination. There are 8 message sets in this category:</p>
          <list list-type="bullet">
            <list-item>
              <p>mRNA and DNA</p>
            </list-item>
            <list-item>
              <p>Infertility/youth infertility</p>
            </list-item>
            <list-item>
              <p>Underlying medical conditions</p>
            </list-item>
            <list-item>
              <p>Your heart/your child’s heart</p>
            </list-item>
            <list-item>
              <p>Guillain-Barré syndrome (GBS; adults only)</p>
            </list-item>
            <list-item>
              <p>Blood clots (adults only)</p>
            </list-item>
            <list-item>
              <p>Side effects</p>
            </list-item>
            <list-item>
              <p>Child is too young (parents only)</p>
            </list-item>
          </list>
        </sec>
        <sec>
          <title>Vaccine Effectiveness</title>
          <p>These message subsets seek to demonstrate that the risk of SARS-CoV-2 and the severity of COVID-19 (ie, long-haul COVID-19, hospitalization, and death) are far greater when not vaccinated against COVID-19. These sets further demonstrate that the vaccine is effective and how variants may affect effectiveness. We also discussed the dosing schedule and role of boosters. There are 7 message sets in this category:</p>
          <list list-type="bullet">
            <list-item>
              <p>Unsure if it works</p>
            </list-item>
            <list-item>
              <p>Variants and the vaccine</p>
            </list-item>
            <list-item>
              <p>Natural immunity or vaccine immunity</p>
            </list-item>
            <list-item>
              <p>Too many vaccines</p>
            </list-item>
            <list-item>
              <p>Boosters. Why?</p>
            </list-item>
            <list-item>
              <p>Is it even needed?</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <sec>
        <title>Principal Findings</title>
        <p>Our study aimed to develop and validate a message library for a social marketing campaign to increase COVID-19 vaccination among African Americans. The goal was to provide African American adults and parents with theory-based, culturally appropriate messaging on COVID-19 vaccines to motivate vaccine uptake. We described a multiphase process using community engagement approaches for the message library development with the HBM [<xref ref-type="bibr" rid="ref31">31</xref>], the TRA [<xref ref-type="bibr" rid="ref30">30</xref>], and Kreuter’s [<xref ref-type="bibr" rid="ref32">32</xref>] cultural targeting strategies serving as the conceptual frameworks. Our existing library allowed us to expeditiously adapt the messaging to meet the needs of African Americans. This process can be used by researchers and health care professionals to inform the development of culturally appropriate messages.</p>
        <p>Use of formative research to build theory-based, culturally appropriate messaging while applying community engagement principles is critical for communities to play an active role in disease prevention and control measures, such as COVID-19 vaccination [<xref ref-type="bibr" rid="ref26">26</xref>,<xref ref-type="bibr" rid="ref49">49</xref>]. This method holds great promise in addressing health disparities, yet is in its infancy [<xref ref-type="bibr" rid="ref50">50</xref>,<xref ref-type="bibr" rid="ref51">51</xref>]. Applying Boyer et al’s [<xref ref-type="bibr" rid="ref52">52</xref>] multilevel approach to stakeholder engagement, we had community member involvement at all phases and varying levels to develop a message library to promote COVID-19 vaccination among African Americans. Engagement approaches included formation of a community-academic partnership, a CAP, and inclusion of community interviewees. Having the community-academic partnership and CAP allowed the community voice to be at the root of the messaging. Using each engagement approach, there was a balance of power to ensure that there was bidirectional communication and a deliberative process to foster respect, and even trust in some instances [<xref ref-type="bibr" rid="ref53">53</xref>]. Furthermore, this process increased the likelihood of achieving cultural appropriateness of the messages.</p>
        <p>Content validation has been recognized as a necessary component of message development and is highly valued [<xref ref-type="bibr" rid="ref54">54</xref>]. The feedback provided by experts in the content review process was used to evolve the library with accurate and relevant messages. Furthermore, the suggestions for modification enriched the messages. Messages were further tested with a purposeful sample of African Americans for cultural appropriateness (ie, evidential, linguistics, peripheral, and sociocultural strategies). Our results indicated that African American adults and parents viewed the messages positively and indicated that the messages were <italic>persuasive</italic>, <italic>useful</italic>, and <italic>trustworthy</italic>. Feedback yielded distinct strategies to increase relevance, comprehension, and appeal. It is important to understand the target audiences’ response early to determine the likelihood of message effectiveness for the intervention [<xref ref-type="bibr" rid="ref55">55</xref>].</p>
        <p>Using this feedback from a multiphase process, our final message library yielded 18 message subsets for adults, and there were 17 message subsets for parents that were grounded in theory and cultural-targeting strategies. There were 3 preferred modes (ie, messages, images, and videos) for African American adults and parents. Studies demonstrate that multiple modes of communication are effective in increasing health literacy among populations, and plain-language messages, pictures, and videos are commonly cited, particularly in the context of community-level interventions [<xref ref-type="bibr" rid="ref56">56</xref>]. We believe that this approach will be effective in reaching different characteristics of individuals.</p>
      </sec>
      <sec>
        <title>Strengths</title>
        <p>A major strength of this study is the use of theory and culturally appropriate strategies inclusive of community engagement to develop the COVID-19 message library for African American adults and parents. We used different levels of community engagement (ie, community-academic partnership, CAP, and interviewees) to ensure that the messages met the needs of our target population. In addition, we equipped the community with information about COVID-19 vaccines to ease concerns postvaccination or to make an informed decision about getting the vaccine. Furthermore, these individuals can now serve as education resources to their communities.</p>
        <p>The next step in our partnership will be to test these messages in a 5-month social marketing campaign in a pilot study. Specifically, these messages are used on a website to provide information on COVID-19 vaccines. Shortened versions of these messages are used to market the website. We will evaluate the impact on attitudes, willingness, and self-reported vaccination status to be reported in a future manuscript. If the intervention demonstrates effectiveness, it could prove that theory-based, culturally appropriate messages in a social marketing campaign can be used as a motivational tool among African Americans.</p>
      </sec>
      <sec>
        <title>Limitations</title>
        <p>This study has limitations. Messages may not be generalizable to African Americans outside the southeastern United States. We had a small, purposeful sample, yet findings explained diverse perspectives to ensure messages encompassed multiple viewpoints toward the vaccine. There is potential for selection bias among content experts as they are medical professionals and clinicians from different disciplines and with clinical or research expertise. Furthermore, lack of access (ie, geographical barriers) to the vaccine could prevent uptake regardless of other concerns being addressed.</p>
      </sec>
      <sec>
        <title>Conclusion</title>
        <p>Vaccine hesitancy continues to negatively impact COVID-19 vaccination among African Americans. Effective interventions are needed to increase vaccine uptake. We believe we have developed validated and pretested theory-based, culturally appropriate messages that can be motivational in different interventions aimed at increasing the COVID-19 vaccination rate among African Americans.</p>
      </sec>
    </sec>
  </body>
  <back>
    <app-group>
      <supplementary-material id="app1">
        <label>Multimedia Appendix 1</label>
        <p>Methods and results of the literature search.</p>
        <media xlink:href="formative_v6i7e38781_app1.docx" xlink:title="DOCX File , 37 KB"/>
      </supplementary-material>
      <supplementary-material id="app2">
        <label>Multimedia Appendix 2</label>
        <p>Qualitative quotations for themes.</p>
        <media xlink:href="formative_v6i7e38781_app2.docx" xlink:title="DOCX File , 17 KB"/>
      </supplementary-material>
    </app-group>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term id="abb1">CAP</term>
          <def>
            <p>community advisory panel</p>
          </def>
        </def-item>
        <def-item>
          <term id="abb2">CHEN</term>
          <def>
            <p>Congregational Health and Education Network</p>
          </def>
        </def-item>
        <def-item>
          <term id="abb3">EUA</term>
          <def>
            <p>Emergency Use Authorization</p>
          </def>
        </def-item>
        <def-item>
          <term id="abb4">GBS</term>
          <def>
            <p>Guillain-Barré syndrome</p>
          </def>
        </def-item>
        <def-item>
          <term id="abb5">HBM</term>
          <def>
            <p>Health Belief Model</p>
          </def>
        </def-item>
        <def-item>
          <term id="abb6">mRNA</term>
          <def>
            <p>messenger RNA</p>
          </def>
        </def-item>
        <def-item>
          <term id="abb7">SMOG</term>
          <def>
            <p>Simple Measure of Gobbledygook</p>
          </def>
        </def-item>
        <def-item>
          <term id="abb8">TRA</term>
          <def>
            <p>Theory of Reasoned Action</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <ack>
      <p>The authors thank members of the African American community for shedding light on the reasons for COVID-19 vaccination hesitancy. We also thank the COVID-19 experts for their invaluable insights into the intervention, particularly its content, images, and channels of delivery. This work was supported by the National Institute on Minority Health and Health Disparities (Award 3U54MD007586-34S7), the National Cancer Institute of the National Institutes of Health (Award P30CA021765 and 1K01CA237748-01A1), and the American Lebanese and Syrian Associated Charities (ALSAC) of St Jude Children’s Research Hospital. This work is also supported by a subaward from the Association of American Medical Colleges through its cooperative agreement with the Centers for Disease Control and Prevention (CDC): “Improving Clinical and Public Health Outcomes through National Partnerships to Prevent and Control Emerging and Re-Emerging Infectious Disease Threats” (Award 6 NU50CK000586-02-02). The CDC is an agency within the Department of Health and Human Services (HHS). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, the CDC, or the HHS and should not be considered an endorsement by the federal government.</p>
    </ack>
    <fn-group>
      <fn fn-type="con">
        <p>JCE was responsible for conceptualization, methodology, validation, formal analysis, resources, data curation, writing—original draft, writing—review and editing, visualization, supervision, planning administration, and funding acquisition; HMB and JD for conceptualization, writing—review and editing, visualization, supervision, planning administration, and funding acquisition; MS for conceptualization, writing—review and editing, visualization, and funding acquisition; KC and OL for conceptualization and writing—review and editing; and DS and KB for formal analysis and writing—review and editing.</p>
      </fn>
      <fn fn-type="conflict">
        <p>None declared.</p>
      </fn>
    </fn-group>
    <ref-list>
      <ref id="ref1">
        <label>1</label>
        <nlm-citation citation-type="web">
          <person-group person-group-type="author">
            <collab>Centers for Disease Control and Prevention</collab>
          </person-group>
          <source>Different COVID-19 Vaccines</source>
          <year>2022</year>
          <access-date>2022-01-21</access-date>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines.html">https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines.html</ext-link>
          </comment>
        </nlm-citation>
      </ref>
      <ref id="ref2">
        <label>2</label>
        <nlm-citation citation-type="web">
          <person-group person-group-type="author">
            <collab>Centers for Disease Control and Prevention</collab>
          </person-group>
          <source>COVID-19 Vaccines Are Effective</source>
          <year>2022</year>
          <access-date>2022-03-11</access-date>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://www.cdc.gov/coronavirus/2019-ncov/vaccines/effectiveness/index.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Fvaccines%2Feffectiveness.html">https://www.cdc.gov/coronavirus/2019-ncov/vaccines/effectiveness/index.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Fvaccines%2Feffectiveness.html</ext-link>
          </comment>
        </nlm-citation>
      </ref>
      <ref id="ref3">
        <label>3</label>
        <nlm-citation citation-type="web">
          <person-group person-group-type="author">
            <collab>Centers for Disease Control and Prevention</collab>
          </person-group>
          <source>Demographic Characteristics of People Receiving COVID-19 Vaccinations in the United States</source>
          <year>2022</year>
          <access-date>2022-03-10</access-date>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://covid.cdc.gov/covid-data-tracker/#vaccinations_vacc-total-admin-rate-total">https://covid.cdc.gov/covid-data-tracker/#vaccinations_vacc-total-admin-rate-total</ext-link>
          </comment>
        </nlm-citation>
      </ref>
      <ref id="ref4">
        <label>4</label>
        <nlm-citation citation-type="web">
          <person-group person-group-type="author">
            <collab>Centers for Disease Control and Prevention</collab>
          </person-group>
          <source>Hospitalization and Death by Race/Ethnicity</source>
          <year>2022</year>
          <access-date>2022-03-25</access-date>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://www.cdc.gov/coronavirus/2019-ncov/covid-data/investigations-discovery/hospitalization-death-by-race-ethnicity.html">https://www.cdc.gov/coronavirus/2019-ncov/covid-data/investigations-discovery/hospitalization-death-by-race-ethnicity.html</ext-link>
          </comment>
        </nlm-citation>
      </ref>
      <ref id="ref5">
        <label>5</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Webb Hooper</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Nápoles</surname>
              <given-names>AM</given-names>
            </name>
            <name name-style="western">
              <surname>Pérez-Stable</surname>
              <given-names>EJ</given-names>
            </name>
          </person-group>
          <article-title>No populations left behind: vaccine hesitancy and equitable diffusion of effective COVID-19 vaccines</article-title>
          <source>J Gen Intern Med</source>
          <year>2021</year>
          <month>07</month>
          <day>22</day>
          <volume>36</volume>
          <issue>7</issue>
          <fpage>2130</fpage>
          <lpage>2133</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="http://europepmc.org/abstract/MED/33754319"/>
          </comment>
          <pub-id pub-id-type="doi">10.1007/s11606-021-06698-5</pub-id>
          <pub-id pub-id-type="medline">33754319</pub-id>
          <pub-id pub-id-type="pii">10.1007/s11606-021-06698-5</pub-id>
          <pub-id pub-id-type="pmcid">PMC7985226</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref6">
        <label>6</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Willis</surname>
              <given-names>DE</given-names>
            </name>
            <name name-style="western">
              <surname>Andersen</surname>
              <given-names>JA</given-names>
            </name>
            <name name-style="western">
              <surname>Bryant-Moore</surname>
              <given-names>K</given-names>
            </name>
            <name name-style="western">
              <surname>Selig</surname>
              <given-names>JP</given-names>
            </name>
            <name name-style="western">
              <surname>Long</surname>
              <given-names>CR</given-names>
            </name>
            <name name-style="western">
              <surname>Felix</surname>
              <given-names>HC</given-names>
            </name>
            <name name-style="western">
              <surname>Curran</surname>
              <given-names>GM</given-names>
            </name>
            <name name-style="western">
              <surname>McElfish</surname>
              <given-names>PA</given-names>
            </name>
          </person-group>
          <article-title>COVID-19 vaccine hesitancy: race/ethnicity, trust, and fear</article-title>
          <source>Clin Transl Sci</source>
          <year>2021</year>
          <month>11</month>
          <day>02</day>
          <volume>14</volume>
          <issue>6</issue>
          <fpage>2200</fpage>
          <lpage>2207</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="http://europepmc.org/abstract/MED/34213073"/>
          </comment>
          <pub-id pub-id-type="doi">10.1111/cts.13077</pub-id>
          <pub-id pub-id-type="medline">34213073</pub-id>
          <pub-id pub-id-type="pmcid">PMC8444681</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref7">
        <label>7</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Cunningham-Erves</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Mayer</surname>
              <given-names>CS</given-names>
            </name>
            <name name-style="western">
              <surname>Han</surname>
              <given-names>X</given-names>
            </name>
            <name name-style="western">
              <surname>Fike</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Yu</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Tousey</surname>
              <given-names>PM</given-names>
            </name>
            <name name-style="western">
              <surname>Schlundt</surname>
              <given-names>DG</given-names>
            </name>
            <name name-style="western">
              <surname>Gupta</surname>
              <given-names>DK</given-names>
            </name>
            <name name-style="western">
              <surname>Mumma</surname>
              <given-names>MT</given-names>
            </name>
            <name name-style="western">
              <surname>Walkley</surname>
              <given-names>D</given-names>
            </name>
            <name name-style="western">
              <surname>Steinwandel</surname>
              <given-names>MD</given-names>
            </name>
            <name name-style="western">
              <surname>Edwards</surname>
              <given-names>KM</given-names>
            </name>
            <name name-style="western">
              <surname>Lipworth</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Sanderson</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Shu</surname>
              <given-names>X</given-names>
            </name>
            <name name-style="western">
              <surname>Shrubsole</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <article-title>Factors influencing intent to receive COVID-19 vaccination among Black and White adults in the southeastern United States, October - December 2020</article-title>
          <source>Hum Vaccin Immunother</source>
          <year>2021</year>
          <month>12</month>
          <day>02</day>
          <volume>17</volume>
          <issue>12</issue>
          <fpage>4761</fpage>
          <lpage>4798</lpage>
          <pub-id pub-id-type="doi">10.1080/21645515.2021.1984134</pub-id>
          <pub-id pub-id-type="medline">34847822</pub-id>
          <pub-id pub-id-type="pmcid">PMC8903908</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref8">
        <label>8</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>McElfish</surname>
              <given-names>PA</given-names>
            </name>
            <name name-style="western">
              <surname>Willis</surname>
              <given-names>DE</given-names>
            </name>
            <name name-style="western">
              <surname>Shah</surname>
              <given-names>SK</given-names>
            </name>
            <name name-style="western">
              <surname>Bryant-Moore</surname>
              <given-names>K</given-names>
            </name>
            <name name-style="western">
              <surname>Rojo</surname>
              <given-names>MO</given-names>
            </name>
            <name name-style="western">
              <surname>Selig</surname>
              <given-names>JP</given-names>
            </name>
          </person-group>
          <article-title>Sociodemographic determinants of COVID-19 vaccine hesitancy, fear of infection, and protection self-efficacy</article-title>
          <source>J Prim Care Community Health</source>
          <year>2021</year>
          <month>08</month>
          <day>24</day>
          <volume>12</volume>
          <fpage>21501327211040746</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://journals.sagepub.com/doi/10.1177/21501327211040746?url_ver=Z39.88-2003&#38;rfr_id=ori:rid:crossref.org&#38;rfr_dat=cr_pub%3dpubmed"/>
          </comment>
          <pub-id pub-id-type="doi">10.1177/21501327211040746</pub-id>
          <pub-id pub-id-type="medline">34427126</pub-id>
          <pub-id pub-id-type="pmcid">PMC8388227</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref9">
        <label>9</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Majee</surname>
              <given-names>W</given-names>
            </name>
            <name name-style="western">
              <surname>Anakwe</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Onyeaka</surname>
              <given-names>K</given-names>
            </name>
            <name name-style="western">
              <surname>Harvey</surname>
              <given-names>IS</given-names>
            </name>
          </person-group>
          <article-title>The past is so present: understanding COVID-19 vaccine hesitancy among African American adults using qualitative data</article-title>
          <source>J Racial Ethn Health Disparities</source>
          <year>2022</year>
          <month>02</month>
          <day>19</day>
          <fpage>1</fpage>
          <lpage>13</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="http://europepmc.org/abstract/MED/35182372"/>
          </comment>
          <pub-id pub-id-type="doi">10.1007/s40615-022-01236-3</pub-id>
          <pub-id pub-id-type="medline">35182372</pub-id>
          <pub-id pub-id-type="pii">10.1007/s40615-022-01236-3</pub-id>
          <pub-id pub-id-type="pmcid">PMC8857529</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref10">
        <label>10</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Kerrigan</surname>
              <given-names>D</given-names>
            </name>
            <name name-style="western">
              <surname>Mantsios</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Karver</surname>
              <given-names>TS</given-names>
            </name>
            <name name-style="western">
              <surname>Davis</surname>
              <given-names>W</given-names>
            </name>
            <name name-style="western">
              <surname>Taggart</surname>
              <given-names>T</given-names>
            </name>
            <name name-style="western">
              <surname>Calabrese</surname>
              <given-names>SK</given-names>
            </name>
            <name name-style="western">
              <surname>Mathews</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Robinson</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Ruffin</surname>
              <given-names>R</given-names>
            </name>
            <name name-style="western">
              <surname>Feaster-Bethea</surname>
              <given-names>G</given-names>
            </name>
            <name name-style="western">
              <surname>Quinteros-Grady</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Galvis</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Reyes</surname>
              <given-names>R</given-names>
            </name>
            <name name-style="western">
              <surname>Martinez Chio</surname>
              <given-names>G</given-names>
            </name>
            <name name-style="western">
              <surname>Tesfahun</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Lane</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Peeks</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Henderson</surname>
              <given-names>KM</given-names>
            </name>
            <name name-style="western">
              <surname>Harris</surname>
              <given-names>KM</given-names>
            </name>
          </person-group>
          <article-title>Context and considerations for the development of community-informed health communication messaging to support equitable uptake of COVID-19 vaccines among communities of color in Washington, DC</article-title>
          <source>J Racial Ethn Health Disparities</source>
          <year>2022</year>
          <month>02</month>
          <day>03</day>
          <fpage>1</fpage>
          <lpage>15</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="http://europepmc.org/abstract/MED/35118609"/>
          </comment>
          <pub-id pub-id-type="doi">10.1007/s40615-022-01231-8</pub-id>
          <pub-id pub-id-type="medline">35118609</pub-id>
          <pub-id pub-id-type="pii">10.1007/s40615-022-01231-8</pub-id>
          <pub-id pub-id-type="pmcid">PMC8812353</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref11">
        <label>11</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Sharma</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Batra</surname>
              <given-names>K</given-names>
            </name>
            <name name-style="western">
              <surname>Batra</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>A theory-based analysis of COVID-19 vaccine hesitancy among African Americans in the United States: a recent evidence</article-title>
          <source>Healthcare (Basel)</source>
          <year>2021</year>
          <month>09</month>
          <day>27</day>
          <volume>9</volume>
          <issue>10</issue>
          <fpage>1273</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://www.mdpi.com/resolver?pii=healthcare9101273"/>
          </comment>
          <pub-id pub-id-type="doi">10.3390/healthcare9101273</pub-id>
          <pub-id pub-id-type="medline">34682953</pub-id>
          <pub-id pub-id-type="pii">healthcare9101273</pub-id>
          <pub-id pub-id-type="pmcid">PMC8535568</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref12">
        <label>12</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Bogart</surname>
              <given-names>LM</given-names>
            </name>
            <name name-style="western">
              <surname>Dong</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Gandhi</surname>
              <given-names>P</given-names>
            </name>
            <name name-style="western">
              <surname>Klein</surname>
              <given-names>DJ</given-names>
            </name>
            <name name-style="western">
              <surname>Smith</surname>
              <given-names>TL</given-names>
            </name>
            <name name-style="western">
              <surname>Ryan</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Ojikutu</surname>
              <given-names>BO</given-names>
            </name>
          </person-group>
          <article-title>COVID-19 vaccine intentions and mistrust in a national sample of Black Americans</article-title>
          <source>J Natl Med Assoc</source>
          <year>2022</year>
          <month>01</month>
          <volume>113</volume>
          <issue>6</issue>
          <fpage>599</fpage>
          <lpage>611</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="http://europepmc.org/abstract/MED/34158171"/>
          </comment>
          <pub-id pub-id-type="doi">10.1016/j.jnma.2021.05.011</pub-id>
          <pub-id pub-id-type="medline">34158171</pub-id>
          <pub-id pub-id-type="pii">S0027-9684(21)00082-1</pub-id>
          <pub-id pub-id-type="pmcid">PMC8214755</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref13">
        <label>13</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Momplaisir</surname>
              <given-names>F</given-names>
            </name>
            <name name-style="western">
              <surname>Haynes</surname>
              <given-names>N</given-names>
            </name>
            <name name-style="western">
              <surname>Nkwihoreze</surname>
              <given-names>H</given-names>
            </name>
            <name name-style="western">
              <surname>Nelson</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Werner</surname>
              <given-names>RM</given-names>
            </name>
            <name name-style="western">
              <surname>Jemmott</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Understanding drivers of coronavirus disease 2019 vaccine hesitancy among Blacks</article-title>
          <source>Clin Infect Dis</source>
          <year>2021</year>
          <month>11</month>
          <day>16</day>
          <volume>73</volume>
          <issue>10</issue>
          <fpage>1784</fpage>
          <lpage>1789</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="http://europepmc.org/abstract/MED/33560346"/>
          </comment>
          <pub-id pub-id-type="doi">10.1093/cid/ciab102</pub-id>
          <pub-id pub-id-type="medline">33560346</pub-id>
          <pub-id pub-id-type="pii">6131729</pub-id>
          <pub-id pub-id-type="pmcid">PMC7929035</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref14">
        <label>14</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Bajaj</surname>
              <given-names>SS</given-names>
            </name>
            <name name-style="western">
              <surname>Stanford</surname>
              <given-names>FC</given-names>
            </name>
          </person-group>
          <article-title>Beyond Tuskegee — vaccine distrust and everyday racism</article-title>
          <source>N Engl J Med</source>
          <year>2021</year>
          <month>02</month>
          <day>04</day>
          <volume>384</volume>
          <issue>5</issue>
          <fpage>e12</fpage>
          <pub-id pub-id-type="doi">10.1056/nejmpv2035827</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref15">
        <label>15</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Khubchandani</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Macias</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>COVID-19 vaccination hesitancy in Hispanics and African-Americans: a review and recommendations for practice</article-title>
          <source>Brain Behav Immun Health</source>
          <year>2021</year>
          <month>08</month>
          <volume>15</volume>
          <fpage>100277</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://linkinghub.elsevier.com/retrieve/pii/S2666-3546(21)00080-6"/>
          </comment>
          <pub-id pub-id-type="doi">10.1016/j.bbih.2021.100277</pub-id>
          <pub-id pub-id-type="medline">34036287</pub-id>
          <pub-id pub-id-type="pii">S2666-3546(21)00080-6</pub-id>
          <pub-id pub-id-type="pmcid">PMC8137342</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref16">
        <label>16</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Reddy</surname>
              <given-names>B</given-names>
            </name>
            <name name-style="western">
              <surname>Gupta</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Importance of effective communication during COVID-19 infodemic</article-title>
          <source>J Family Med Prim Care</source>
          <year>2020</year>
          <month>08</month>
          <volume>9</volume>
          <issue>8</issue>
          <fpage>3793</fpage>
          <lpage>3796</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="http://europepmc.org/abstract/MED/33110769"/>
          </comment>
          <pub-id pub-id-type="doi">10.4103/jfmpc.jfmpc_719_20</pub-id>
          <pub-id pub-id-type="medline">33110769</pub-id>
          <pub-id pub-id-type="pii">JFMPC-9-3793</pub-id>
          <pub-id pub-id-type="pmcid">PMC7586512</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref17">
        <label>17</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Cooper</surname>
              <given-names>LA</given-names>
            </name>
            <name name-style="western">
              <surname>Stoney</surname>
              <given-names>CM</given-names>
            </name>
          </person-group>
          <article-title>Messages to increase COVID-19 knowledge in communities of color: what matters most?</article-title>
          <source>Ann Intern Med</source>
          <year>2021</year>
          <month>04</month>
          <volume>174</volume>
          <issue>4</issue>
          <fpage>554</fpage>
          <lpage>555</lpage>
          <pub-id pub-id-type="doi">10.7326/m20-8057</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref18">
        <label>18</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>James</surname>
              <given-names>EK</given-names>
            </name>
            <name name-style="western">
              <surname>Bokemper</surname>
              <given-names>SE</given-names>
            </name>
            <name name-style="western">
              <surname>Gerber</surname>
              <given-names>AS</given-names>
            </name>
            <name name-style="western">
              <surname>Omer</surname>
              <given-names>SB</given-names>
            </name>
            <name name-style="western">
              <surname>Huber</surname>
              <given-names>GA</given-names>
            </name>
          </person-group>
          <article-title>Persuasive messaging to increase COVID-19 vaccine uptake intentions</article-title>
          <source>Vaccine</source>
          <year>2021</year>
          <month>12</month>
          <day>03</day>
          <volume>39</volume>
          <issue>49</issue>
          <fpage>7158</fpage>
          <lpage>7165</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="http://europepmc.org/abstract/MED/34774363"/>
          </comment>
          <pub-id pub-id-type="doi">10.1016/j.vaccine.2021.10.039</pub-id>
          <pub-id pub-id-type="medline">34774363</pub-id>
          <pub-id pub-id-type="pii">S0264-410X(21)01368-2</pub-id>
          <pub-id pub-id-type="pmcid">PMC8531257</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref19">
        <label>19</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Borah</surname>
              <given-names>P</given-names>
            </name>
            <name name-style="western">
              <surname>Hwang</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Hsu</surname>
              <given-names>YC</given-names>
            </name>
          </person-group>
          <article-title>COVID-19 vaccination attitudes and intention: message framing and the moderating role of perceived vaccine benefits</article-title>
          <source>J Health Commun</source>
          <year>2021</year>
          <month>08</month>
          <day>03</day>
          <volume>26</volume>
          <issue>8</issue>
          <fpage>523</fpage>
          <lpage>533</lpage>
          <pub-id pub-id-type="doi">10.1080/10810730.2021.1966687</pub-id>
          <pub-id pub-id-type="medline">34424140</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref20">
        <label>20</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Privor-Dumm</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>King</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Community-based strategies to engage pastors can help address vaccine hesitancy and health disparities in Black communities</article-title>
          <source>J Health Commun</source>
          <year>2020</year>
          <month>10</month>
          <day>02</day>
          <volume>25</volume>
          <issue>10</issue>
          <fpage>827</fpage>
          <lpage>830</lpage>
          <pub-id pub-id-type="doi">10.1080/10810730.2021.1873463</pub-id>
          <pub-id pub-id-type="medline">33719889</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref21">
        <label>21</label>
        <nlm-citation citation-type="web">
          <person-group person-group-type="author">
            <collab>World Health Organization</collab>
          </person-group>
          <source>COVID-19 Message Library</source>
          <access-date>2022-07-07</access-date>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://www.who.int/publications/i/item/covid-19-message-library">https://www.who.int/publications/i/item/covid-19-message-library</ext-link>
          </comment>
        </nlm-citation>
      </ref>
      <ref id="ref22">
        <label>22</label>
        <nlm-citation citation-type="web">
          <person-group person-group-type="author">
            <collab>The Rockefellar Foundation</collab>
          </person-group>
          <source>Vaccine Confidence Message Brief</source>
          <year>2021</year>
          <access-date>2022-07-07</access-date>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://www.covidcollaborative.us/assets/uploads/pdf/STAT-Vaccine-Confidence-Message-Brief.pdf">https://www.covidcollaborative.us/assets/uploads/pdf/STAT-Vaccine-Confidence-Message-Brief.pdf</ext-link>
          </comment>
        </nlm-citation>
      </ref>
      <ref id="ref23">
        <label>23</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Jensen</surname>
              <given-names>UT</given-names>
            </name>
            <name name-style="western">
              <surname>Ayers</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Koskan</surname>
              <given-names>AM</given-names>
            </name>
          </person-group>
          <article-title>Video-based messages to reduce COVID-19 vaccine hesitancy and nudge vaccination intentions</article-title>
          <source>PLoS One</source>
          <year>2022</year>
          <month>4</month>
          <day>6</day>
          <volume>17</volume>
          <issue>4</issue>
          <fpage>e0265736</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://dx.plos.org/10.1371/journal.pone.0265736"/>
          </comment>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0265736</pub-id>
          <pub-id pub-id-type="medline">35385505</pub-id>
          <pub-id pub-id-type="pii">PONE-D-21-33528</pub-id>
          <pub-id pub-id-type="pmcid">PMC8985948</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref24">
        <label>24</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Dai</surname>
              <given-names>H</given-names>
            </name>
            <name name-style="western">
              <surname>Saccardo</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Han</surname>
              <given-names>MA</given-names>
            </name>
            <name name-style="western">
              <surname>Roh</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Raja</surname>
              <given-names>N</given-names>
            </name>
            <name name-style="western">
              <surname>Vangala</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Modi</surname>
              <given-names>H</given-names>
            </name>
            <name name-style="western">
              <surname>Pandya</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Sloyan</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Croymans</surname>
              <given-names>DM</given-names>
            </name>
          </person-group>
          <article-title>Behavioural nudges increase COVID-19 vaccinations</article-title>
          <source>Nature</source>
          <year>2021</year>
          <month>09</month>
          <day>02</day>
          <volume>597</volume>
          <issue>7876</issue>
          <fpage>404</fpage>
          <lpage>409</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="http://europepmc.org/abstract/MED/34340242"/>
          </comment>
          <pub-id pub-id-type="doi">10.1038/s41586-021-03843-2</pub-id>
          <pub-id pub-id-type="medline">34340242</pub-id>
          <pub-id pub-id-type="pii">10.1038/s41586-021-03843-2</pub-id>
          <pub-id pub-id-type="pmcid">PMC8443442</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref25">
        <label>25</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Dada</surname>
              <given-names>D</given-names>
            </name>
            <name name-style="western">
              <surname>Djiometio</surname>
              <given-names>JN</given-names>
            </name>
            <name name-style="western">
              <surname>McFadden</surname>
              <given-names>SM</given-names>
            </name>
            <name name-style="western">
              <surname>Demeke</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Vlahov</surname>
              <given-names>D</given-names>
            </name>
            <name name-style="western">
              <surname>Wilton</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Wang</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Nelson</surname>
              <given-names>LE</given-names>
            </name>
          </person-group>
          <article-title>Strategies that promote equity in COVID-19 vaccine uptake for Black communities: a review</article-title>
          <source>J Urban Health</source>
          <year>2022</year>
          <month>02</month>
          <day>11</day>
          <volume>99</volume>
          <issue>1</issue>
          <fpage>15</fpage>
          <lpage>27</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="http://europepmc.org/abstract/MED/35018612"/>
          </comment>
          <pub-id pub-id-type="doi">10.1007/s11524-021-00594-3</pub-id>
          <pub-id pub-id-type="medline">35018612</pub-id>
          <pub-id pub-id-type="pii">10.1007/s11524-021-00594-3</pub-id>
          <pub-id pub-id-type="pmcid">PMC8751469</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref26">
        <label>26</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Shafiq</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Elharake</surname>
              <given-names>JA</given-names>
            </name>
            <name name-style="western">
              <surname>Malik</surname>
              <given-names>AA</given-names>
            </name>
            <name name-style="western">
              <surname>McFadden</surname>
              <given-names>SM</given-names>
            </name>
            <name name-style="western">
              <surname>Aguolu</surname>
              <given-names>OG</given-names>
            </name>
            <name name-style="western">
              <surname>Omer</surname>
              <given-names>SB</given-names>
            </name>
          </person-group>
          <article-title>COVID-19 sources of information, knowledge, and preventive behaviors among the US adult population</article-title>
          <source>J Public Health Manag Pract</source>
          <year>2021</year>
          <volume>27</volume>
          <issue>3</issue>
          <fpage>278</fpage>
          <lpage>284</lpage>
          <pub-id pub-id-type="doi">10.1097/PHH.0000000000001348</pub-id>
          <pub-id pub-id-type="medline">33762543</pub-id>
          <pub-id pub-id-type="pii">00124784-202105000-00011</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref27">
        <label>27</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Yates</surname>
              <given-names>JF</given-names>
            </name>
            <name name-style="western">
              <surname>de Oliveira</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Culture and decision making</article-title>
          <source>Organ Behav Hum Decis Process</source>
          <year>2016</year>
          <month>09</month>
          <volume>136</volume>
          <fpage>106</fpage>
          <lpage>118</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="http://europepmc.org/abstract/MED/32288179"/>
          </comment>
          <pub-id pub-id-type="doi">10.1016/j.obhdp.2016.05.003</pub-id>
          <pub-id pub-id-type="medline">32288179</pub-id>
          <pub-id pub-id-type="pii">S0749-5978(16)30301-6</pub-id>
          <pub-id pub-id-type="pmcid">PMC7126161</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref28">
        <label>28</label>
        <nlm-citation citation-type="book">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Kreuter</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Farrell</surname>
              <given-names>D</given-names>
            </name>
            <name name-style="western">
              <surname>Olevitch</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Brennan</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <source>Tailored Health Messages: Customizing Communication with Computer Technology</source>
          <year>1999</year>
          <publisher-loc>Mahwah, NJ</publisher-loc>
          <publisher-name>Lawrence Erlbaum</publisher-name>
        </nlm-citation>
      </ref>
      <ref id="ref29">
        <label>29</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Noar</surname>
              <given-names>SM</given-names>
            </name>
            <name name-style="western">
              <surname>Benac</surname>
              <given-names>CN</given-names>
            </name>
            <name name-style="western">
              <surname>Harris</surname>
              <given-names>MS</given-names>
            </name>
          </person-group>
          <article-title>Does tailoring matter? Meta-analytic review of tailored print health behavior change interventions</article-title>
          <source>Psychol Bull</source>
          <year>2007</year>
          <month>07</month>
          <volume>133</volume>
          <issue>4</issue>
          <fpage>673</fpage>
          <lpage>693</lpage>
          <pub-id pub-id-type="doi">10.1037/0033-2909.133.4.673</pub-id>
          <pub-id pub-id-type="medline">17592961</pub-id>
          <pub-id pub-id-type="pii">2007-09203-006</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref30">
        <label>30</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Hill</surname>
              <given-names>RJ</given-names>
            </name>
            <name name-style="western">
              <surname>Fishbein</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Ajzen</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>Belief, attitude, intention and behavior: an introduction to theory and research</article-title>
          <source>Contemp Sociol</source>
          <year>1977</year>
          <month>03</month>
          <volume>6</volume>
          <issue>2</issue>
          <fpage>244</fpage>
          <pub-id pub-id-type="doi">10.2307/2065853</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref31">
        <label>31</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Rosenstock</surname>
              <given-names>IM</given-names>
            </name>
          </person-group>
          <article-title>The Health Belief Model and preventive health behavior</article-title>
          <source>Health Educ Monogr</source>
          <year>1974</year>
          <month>12</month>
          <day>01</day>
          <volume>2</volume>
          <issue>4</issue>
          <fpage>354</fpage>
          <lpage>386</lpage>
          <pub-id pub-id-type="doi">10.1177/109019817400200405</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref32">
        <label>32</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Kreuter</surname>
              <given-names>MW</given-names>
            </name>
            <name name-style="western">
              <surname>Lukwago</surname>
              <given-names>SN</given-names>
            </name>
            <name name-style="western">
              <surname>Bucholtz</surname>
              <given-names>RDDC</given-names>
            </name>
            <name name-style="western">
              <surname>Clark</surname>
              <given-names>EM</given-names>
            </name>
            <name name-style="western">
              <surname>Sanders-Thompson</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>Achieving cultural appropriateness in health promotion programs: targeted and tailored approaches</article-title>
          <source>Health Educ Behav</source>
          <year>2003</year>
          <month>04</month>
          <volume>30</volume>
          <issue>2</issue>
          <fpage>133</fpage>
          <lpage>146</lpage>
          <pub-id pub-id-type="doi">10.1177/1090198102251021</pub-id>
          <pub-id pub-id-type="medline">12693519</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref33">
        <label>33</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Jedele</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Ismail</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Evaluation of a multifaceted social marketing campaign to increase awareness of and screening for oral cancer in African Americans</article-title>
          <source>Community Dent Oral Epidemiol</source>
          <year>2010</year>
          <month>08</month>
          <volume>38</volume>
          <issue>4</issue>
          <fpage>371</fpage>
          <lpage>382</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1600-0528.2010.00545.x</pub-id>
          <pub-id pub-id-type="medline">20646014</pub-id>
          <pub-id pub-id-type="pii">COM545</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref34">
        <label>34</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Ngui</surname>
              <given-names>E</given-names>
            </name>
            <name name-style="western">
              <surname>Hamilton</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Nugent</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Simpson</surname>
              <given-names>P</given-names>
            </name>
            <name name-style="western">
              <surname>Willis</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Evaluation of a social marketing campaign to increase awareness of immunizations for urban low-income children</article-title>
          <source>WMJ</source>
          <year>2015</year>
          <month>02</month>
          <volume>114</volume>
          <issue>1</issue>
          <fpage>10</fpage>
          <lpage>15</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://wmjonline.org/wp-content/uploads/2015/114/1/10.pdf"/>
          </comment>
          <pub-id pub-id-type="medline">25845130</pub-id>
          <pub-id pub-id-type="pmcid">PMC4390996</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref35">
        <label>35</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Graham</surname>
              <given-names>JL</given-names>
            </name>
            <name name-style="western">
              <surname>Andreasen</surname>
              <given-names>AR</given-names>
            </name>
          </person-group>
          <article-title>Marketing social change: changing behavior to promote health, social development, and the environment</article-title>
          <source>J Mark Res</source>
          <year>1997</year>
          <month>05</month>
          <volume>34</volume>
          <issue>2</issue>
          <fpage>294</fpage>
          <pub-id pub-id-type="doi">10.2307/3151867</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref36">
        <label>36</label>
        <nlm-citation citation-type="web">
          <person-group person-group-type="author">
            <collab>Nashville General Hospital</collab>
          </person-group>
          <source>Congregational Health and Education Network</source>
          <access-date>2022-03-11</access-date>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://nashvillegeneral.org/resources/chen">https://nashvillegeneral.org/resources/chen</ext-link>
          </comment>
        </nlm-citation>
      </ref>
      <ref id="ref37">
        <label>37</label>
        <nlm-citation citation-type="book">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Creswell</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <source>Qualitative Inquiry and Research Design: Choosing among Five Traditions</source>
          <year>1998</year>
          <publisher-loc>Newbury Park, CA</publisher-loc>
          <publisher-name>SAGE Publications</publisher-name>
        </nlm-citation>
      </ref>
      <ref id="ref38">
        <label>38</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Harris</surname>
              <given-names>PA</given-names>
            </name>
            <name name-style="western">
              <surname>Scott</surname>
              <given-names>KW</given-names>
            </name>
            <name name-style="western">
              <surname>Lebo</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Hassan</surname>
              <given-names>N</given-names>
            </name>
            <name name-style="western">
              <surname>Lightner</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Pulley</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>ResearchMatch: a national registry to recruit volunteers for clinical research</article-title>
          <source>Acad Med</source>
          <year>2012</year>
          <volume>87</volume>
          <issue>1</issue>
          <fpage>66</fpage>
          <lpage>73</lpage>
          <pub-id pub-id-type="doi">10.1097/acm.0b013e31823ab7d2</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref39">
        <label>39</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Harris</surname>
              <given-names>PA</given-names>
            </name>
            <name name-style="western">
              <surname>Taylor</surname>
              <given-names>R</given-names>
            </name>
            <name name-style="western">
              <surname>Thielke</surname>
              <given-names>R</given-names>
            </name>
            <name name-style="western">
              <surname>Payne</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Gonzalez</surname>
              <given-names>N</given-names>
            </name>
            <name name-style="western">
              <surname>Conde</surname>
              <given-names>JG</given-names>
            </name>
          </person-group>
          <article-title>Research electronic data capture (REDCap): a metadata-driven methodology and workflow process for providing translational research informatics support</article-title>
          <source>J Biomed Inform</source>
          <year>2009</year>
          <month>04</month>
          <volume>42</volume>
          <issue>2</issue>
          <fpage>377</fpage>
          <lpage>381</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://linkinghub.elsevier.com/retrieve/pii/S1532-0464(08)00122-6"/>
          </comment>
          <pub-id pub-id-type="doi">10.1016/j.jbi.2008.08.010</pub-id>
          <pub-id pub-id-type="medline">18929686</pub-id>
          <pub-id pub-id-type="pii">S1532-0464(08)00122-6</pub-id>
          <pub-id pub-id-type="pmcid">PMC2700030</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref40">
        <label>40</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Tong</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Sainsbury</surname>
              <given-names>P</given-names>
            </name>
            <name name-style="western">
              <surname>Craig</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups</article-title>
          <source>Int J Qual Health Care</source>
          <year>2007</year>
          <month>12</month>
          <volume>19</volume>
          <issue>6</issue>
          <fpage>349</fpage>
          <lpage>357</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="http://intqhc.oxfordjournals.org/cgi/pmidlookup?view=long&#38;pmid=17872937"/>
          </comment>
          <pub-id pub-id-type="doi">10.1093/intqhc/mzm042</pub-id>
          <pub-id pub-id-type="medline">17872937</pub-id>
          <pub-id pub-id-type="pii">mzm042</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref41">
        <label>41</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Azungah</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Qualitative research: deductive and inductive approaches to data analysis</article-title>
          <source>Qual Res J</source>
          <year>2018</year>
          <month>10</month>
          <day>31</day>
          <volume>18</volume>
          <issue>4</issue>
          <fpage>383</fpage>
          <lpage>400</lpage>
          <pub-id pub-id-type="doi">10.1108/qrj-d-18-00035</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref42">
        <label>42</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Fereday</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Muir-Cochrane</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Demonstrating rigor using thematic analysis: a hybrid approach of inductive and deductive coding and theme development</article-title>
          <source>Int J Qual Methods</source>
          <year>2016</year>
          <month>11</month>
          <day>29</day>
          <volume>5</volume>
          <issue>1</issue>
          <fpage>80</fpage>
          <lpage>92</lpage>
          <pub-id pub-id-type="doi">10.1177/160940690600500107</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref43">
        <label>43</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>LAWSHE</surname>
              <given-names>CH</given-names>
            </name>
          </person-group>
          <article-title>A quantitative approach to content validity</article-title>
          <source>Pers Psychol</source>
          <year>1975</year>
          <month>12</month>
          <volume>28</volume>
          <issue>4</issue>
          <fpage>563</fpage>
          <lpage>575</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1744-6570.1975.tb01393.x</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref44">
        <label>44</label>
        <nlm-citation citation-type="web">
          <source>Centers for Disease Control and Prevention</source>
          <access-date>2022-07-07</access-date>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://www.cdc.gov/">https://www.cdc.gov/</ext-link>
          </comment>
        </nlm-citation>
      </ref>
      <ref id="ref45">
        <label>45</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Flesch</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>A new readability yardstick</article-title>
          <source>J Appl Psychol</source>
          <year>1948</year>
          <month>06</month>
          <volume>32</volume>
          <issue>3</issue>
          <fpage>221</fpage>
          <lpage>233</lpage>
          <pub-id pub-id-type="doi">10.1037/h0057532</pub-id>
          <pub-id pub-id-type="medline">18867058</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref46">
        <label>46</label>
        <nlm-citation citation-type="web">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Kincaid</surname>
              <given-names>JP</given-names>
            </name>
            <name name-style="western">
              <surname>Fishburned</surname>
              <given-names>RP</given-names>
            </name>
            <name name-style="western">
              <surname>Rogers</surname>
              <given-names>RL</given-names>
            </name>
            <name name-style="western">
              <surname>Chissom</surname>
              <given-names>BS</given-names>
            </name>
          </person-group>
          <source>Derivation of New Readability Formulas (Automated Readability Index, Fog Count and Flesch Reading Ease Formula) for Navy Enlisted Personnel</source>
          <access-date>2022-07-07</access-date>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="http://stars.library.ucf.edu/istlibrary/56. ">http://stars.library.ucf.edu/istlibrary/56. </ext-link>
          </comment>
        </nlm-citation>
      </ref>
      <ref id="ref47">
        <label>47</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>McLaughlin</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>SMOG grading: a new readability formula</article-title>
          <source>J Read</source>
          <year>1969</year>
          <volume>12</volume>
          <issue>8</issue>
          <fpage>639</fpage>
          <lpage>646</lpage>
        </nlm-citation>
      </ref>
      <ref id="ref48">
        <label>48</label>
        <nlm-citation citation-type="web">
          <person-group person-group-type="author">
            <collab>Readability Formulas</collab>
          </person-group>
          <source>Free Readability Tools to Check for Reading Levels, Reading Assessment, and Reading Grade Levels</source>
          <access-date>2022-07-07</access-date>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://readabilityformulas.com/">https://readabilityformulas.com/</ext-link>
          </comment>
        </nlm-citation>
      </ref>
      <ref id="ref49">
        <label>49</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Gilmore</surname>
              <given-names>B</given-names>
            </name>
            <name name-style="western">
              <surname>Ndejjo</surname>
              <given-names>R</given-names>
            </name>
            <name name-style="western">
              <surname>Tchetchia</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>de Claro</surname>
              <given-names>V</given-names>
            </name>
            <name name-style="western">
              <surname>Mago</surname>
              <given-names>E</given-names>
            </name>
            <name name-style="western">
              <surname>Diallo</surname>
              <given-names>AA</given-names>
            </name>
            <name name-style="western">
              <surname>Lopes</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Bhattacharyya</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Community engagement for COVID-19 prevention and control: a rapid evidence synthesis</article-title>
          <source>BMJ Glob Health</source>
          <year>2020</year>
          <month>10</month>
          <volume>5</volume>
          <issue>10</issue>
          <fpage>e003188</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://gh.bmj.com/lookup/pmidlookup?view=long&#38;pmid=33051285"/>
          </comment>
          <pub-id pub-id-type="doi">10.1136/bmjgh-2020-003188</pub-id>
          <pub-id pub-id-type="medline">33051285</pub-id>
          <pub-id pub-id-type="pii">bmjgh-2020-003188</pub-id>
          <pub-id pub-id-type="pmcid">PMC7554411</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref50">
        <label>50</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Vastine</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Gittelsohn</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Ethelbah</surname>
              <given-names>B</given-names>
            </name>
            <name name-style="western">
              <surname>Anliker</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Caballero</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Formative research and stakeholder participation in intervention development</article-title>
          <source>Am J Health Behav</source>
          <year>2005</year>
          <month>01</month>
          <day>01</day>
          <volume>29</volume>
          <issue>1</issue>
          <fpage>57</fpage>
          <lpage>69</lpage>
          <pub-id pub-id-type="doi">10.5993/ajhb.29.1.5</pub-id>
          <pub-id pub-id-type="medline">15604050</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref51">
        <label>51</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Cunningham-Erves</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Barajas</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Mayo-Gamble</surname>
              <given-names>TL</given-names>
            </name>
            <name name-style="western">
              <surname>McAfee</surname>
              <given-names>CR</given-names>
            </name>
            <name name-style="western">
              <surname>Hull</surname>
              <given-names>PC</given-names>
            </name>
            <name name-style="western">
              <surname>Sanderson</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Canedo</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Beard</surname>
              <given-names>K</given-names>
            </name>
            <name name-style="western">
              <surname>Wilkins</surname>
              <given-names>CH</given-names>
            </name>
          </person-group>
          <article-title>Formative research to design a culturally-appropriate cancer clinical trial education program to increase participation of African American and Latino communities</article-title>
          <source>BMC Public Health</source>
          <year>2020</year>
          <month>06</month>
          <day>03</day>
          <volume>20</volume>
          <issue>1</issue>
          <fpage>840</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-020-08939-4"/>
          </comment>
          <pub-id pub-id-type="doi">10.1186/s12889-020-08939-4</pub-id>
          <pub-id pub-id-type="medline">32493245</pub-id>
          <pub-id pub-id-type="pii">10.1186/s12889-020-08939-4</pub-id>
          <pub-id pub-id-type="pmcid">PMC7268329</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref52">
        <label>52</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Boyer</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Fair</surname>
              <given-names>A</given-names>
            </name>
            <name name-style="western">
              <surname>Joosten</surname>
              <given-names>Y</given-names>
            </name>
            <name name-style="western">
              <surname>Dolor</surname>
              <given-names>R</given-names>
            </name>
            <name name-style="western">
              <surname>Williams</surname>
              <given-names>N</given-names>
            </name>
            <name name-style="western">
              <surname>Sherden</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>A multilevel approach to stakeholder engagement in the formulation of a clinical data research network</article-title>
          <source>Med Care</source>
          <year>2018</year>
          <volume>56</volume>
          <issue>10 Suppl 1</issue>
          <fpage>S22</fpage>
          <lpage>S26</lpage>
          <pub-id pub-id-type="doi">10.1097/mlr.0000000000000778</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref53">
        <label>53</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Wallerstein</surname>
              <given-names>N</given-names>
            </name>
            <name name-style="western">
              <surname>Muhammad</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Sanchez-Youngman</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Rodriguez Espinosa</surname>
              <given-names>P</given-names>
            </name>
            <name name-style="western">
              <surname>Avila</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Baker</surname>
              <given-names>EA</given-names>
            </name>
            <name name-style="western">
              <surname>Barnett</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Belone</surname>
              <given-names>L</given-names>
            </name>
            <name name-style="western">
              <surname>Golub</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Lucero</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Mahdi</surname>
              <given-names>I</given-names>
            </name>
            <name name-style="western">
              <surname>Noyes</surname>
              <given-names>E</given-names>
            </name>
            <name name-style="western">
              <surname>Nguyen</surname>
              <given-names>T</given-names>
            </name>
            <name name-style="western">
              <surname>Roubideaux</surname>
              <given-names>Y</given-names>
            </name>
            <name name-style="western">
              <surname>Sigo</surname>
              <given-names>R</given-names>
            </name>
            <name name-style="western">
              <surname>Duran</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Power dynamics in community-based participatory research: a multiple-case study analysis of partnering contexts, histories, and practices</article-title>
          <source>Health Educ Behav</source>
          <year>2019</year>
          <month>10</month>
          <day>24</day>
          <volume>46</volume>
          <issue>1_suppl</issue>
          <fpage>19S</fpage>
          <lpage>32S</lpage>
          <pub-id pub-id-type="doi">10.1177/1090198119852998</pub-id>
          <pub-id pub-id-type="medline">31549557</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref54">
        <label>54</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Helitzer</surname>
              <given-names>D</given-names>
            </name>
            <name name-style="western">
              <surname>Hollis</surname>
              <given-names>C</given-names>
            </name>
            <name name-style="western">
              <surname>Cotner</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Oestreicher</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Health literacy demands of written health information materials: an assessment of cervical cancer prevention materials</article-title>
          <source>Cancer Control</source>
          <year>2009</year>
          <month>01</month>
          <day>01</day>
          <volume>16</volume>
          <issue>1</issue>
          <fpage>70</fpage>
          <lpage>78</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://journals.sagepub.com/doi/10.1177/107327480901600111?url_ver=Z39.88-2003&#38;rfr_id=ori:rid:crossref.org&#38;rfr_dat=cr_pub%3dpubmed"/>
          </comment>
          <pub-id pub-id-type="doi">10.1177/107327480901600111</pub-id>
          <pub-id pub-id-type="medline">19078933</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref55">
        <label>55</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Brown</surname>
              <given-names>KM</given-names>
            </name>
            <name name-style="western">
              <surname>Lindenberger</surname>
              <given-names>JH</given-names>
            </name>
            <name name-style="western">
              <surname>Bryant</surname>
              <given-names>CA</given-names>
            </name>
          </person-group>
          <article-title>Using pretesting to ensure your messages and materials are on strategy</article-title>
          <source>Health Promot Pract</source>
          <year>2008</year>
          <month>04</month>
          <day>01</day>
          <volume>9</volume>
          <issue>2</issue>
          <fpage>116</fpage>
          <lpage>122</lpage>
          <pub-id pub-id-type="doi">10.1177/1524839908315134</pub-id>
          <pub-id pub-id-type="medline">18340086</pub-id>
          <pub-id pub-id-type="pii">9/2/116</pub-id>
        </nlm-citation>
      </ref>
      <ref id="ref56">
        <label>56</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Sudore</surname>
              <given-names>R</given-names>
            </name>
            <name name-style="western">
              <surname>Schillinger</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Interventions to improve care for patients with limited health literacy</article-title>
          <source>J Clin Outcomes Manag</source>
          <year>2009</year>
          <month>01</month>
          <day>01</day>
          <volume>16</volume>
          <issue>1</issue>
          <fpage>20</fpage>
          <lpage>29</lpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="http://europepmc.org/abstract/MED/20046798"/>
          </comment>
          <pub-id pub-id-type="medline">20046798</pub-id>
          <pub-id pub-id-type="pmcid">PMC2799039</pub-id>
        </nlm-citation>
      </ref>
    </ref-list>
  </back>
</article>
